HTTP 200 OK
Allow: GET, POST, HEAD, OPTIONS
Content-Type: application/json
Vary: Accept
{
"recordsFiltered": 47012,
"recordsTotal": 47012,
"next": "http://fdaaa.trialstracker.net/api/trials/?format=api&length=300&start=45000",
"previous": "http://fdaaa.trialstracker.net/api/trials/?format=api&length=300&start=44400",
"results": [
{
"registry_id": "NCT05237505",
"publication_url": "https://clinicaltrials.gov/study/NCT05237505",
"title": "The Cardiovascular Consequences of Sleep Apnea Plus COPD (Overlap Syndrome)",
"has_exemption": false,
"start_date": "2024-02-13",
"completion_date": "2028-08-31",
"has_results": false,
"results_due": false,
"sponsor_name": "University of California, San Diego",
"sponsor_slug": "university-of-california-san-diego",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05753046",
"publication_url": "https://clinicaltrials.gov/study/NCT05753046",
"title": "Perioperative Laparoscopic Transversus Abdominis Plane Block During Robotic Assisted Laparoscopic Radical Prostatectomy for Improvement in Postoperative Pain",
"has_exemption": false,
"start_date": "2024-02-19",
"completion_date": "2028-08-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Corewell Health East",
"sponsor_slug": "corewell-health-east",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06242782",
"publication_url": "https://clinicaltrials.gov/study/NCT06242782",
"title": "Vertical Ridge Augmentation Strategies: An Adaptive Randomised Controlled Clinical Trial",
"has_exemption": false,
"start_date": "2024-02-29",
"completion_date": "2028-08-31",
"has_results": false,
"results_due": false,
"sponsor_name": "University College, London",
"sponsor_slug": "university-college-london",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06316297",
"publication_url": "https://clinicaltrials.gov/study/NCT06316297",
"title": "A Phase I/II, Randomized, Placebo-controlled, Multi-arm, Dose-finding Study to Evaluate the Safety, Efficacy and Immunogenicity of an Acne mRNA Vaccine Candidate in Adults With Moderate to Severe Acne 18 to 45 Years of Age",
"has_exemption": false,
"start_date": "2024-04-05",
"completion_date": "2028-08-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Sanofi Pasteur, a Sanofi Company",
"sponsor_slug": "sanofi-pasteur-a-sanofi-company",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06290063",
"publication_url": "https://clinicaltrials.gov/study/NCT06290063",
"title": "Rocky Mountain Cannabis Research Center - Cannabidiol and Older Adult Cannabis Users: A Randomized, Placebo-Controlled Study",
"has_exemption": false,
"start_date": "2024-05-01",
"completion_date": "2028-08-31",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Colorado, Boulder",
"sponsor_slug": "university-of-colorado-boulder",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06082167",
"publication_url": "https://clinicaltrials.gov/study/NCT06082167",
"title": "A Phase 2/3, Randomized, Double-Blind, Controlled Study of Zanzalintinib (XL092) in Combination With Pembrolizumab vs Pembrolizumab in First-Line Treatment of Subjects With PD-L1 Positive Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma",
"has_exemption": false,
"start_date": "2024-06-07",
"completion_date": "2028-08-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Exelixis",
"sponsor_slug": "exelixis",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06239194",
"publication_url": "https://clinicaltrials.gov/study/NCT06239194",
"title": "A Phase 1/2a, Multicenter, First-in-human, Open-label Clinical Trial Evaluating MDX2001 Monotherapy in Patients With Advanced Solid Tumors",
"has_exemption": false,
"start_date": "2024-06-12",
"completion_date": "2028-08-31",
"has_results": false,
"results_due": false,
"sponsor_name": "ModeX Therapeutics, An OPKO Health Company",
"sponsor_slug": "modex-therapeutics-an-opko-health-company",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05826912",
"publication_url": "https://clinicaltrials.gov/study/NCT05826912",
"title": "Multi-Arm Multi-Stage Adaptive Platform Trial (APT) for the Acute Treatment of Traumatic Brain Injury",
"has_exemption": false,
"start_date": "2024-08-01",
"completion_date": "2028-08-31",
"has_results": false,
"results_due": false,
"sponsor_name": "University of California, San Francisco",
"sponsor_slug": "university-of-california-san-francisco",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06449222",
"publication_url": "https://clinicaltrials.gov/study/NCT06449222",
"title": "A Phase II, Multi-site, Randomized, Open-label Clinical Trial to Evaluate the Safety, Efficacy, and Pharmacokinetics of BNT327 at Two Dose Levels in Combination With Chemotherapeutic Agents as First- and Second-line Treatment in Triple-negative Breast Cancer",
"has_exemption": false,
"start_date": "2024-08-26",
"completion_date": "2028-08-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Biontech SE",
"sponsor_slug": "biontech-se",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06377852",
"publication_url": "https://clinicaltrials.gov/study/NCT06377852",
"title": "Comparing Oral Drug Dosing Strategies in Older Patients With Metastatic Breast Cancer to Maximize Tolerance and Reduce Discontinuation: The CDK4/6 Inhibitor Dosing Knowledge (CDK) Study",
"has_exemption": false,
"start_date": "2024-10-29",
"completion_date": "2028-08-31",
"has_results": false,
"results_due": false,
"sponsor_name": "American Society of Clinical Oncology",
"sponsor_slug": "american-society-of-clinical-oncology",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06105164",
"publication_url": "https://clinicaltrials.gov/study/NCT06105164",
"title": "Validation of a Novel Cerebellar-striatal Satiety Circuit in Humans",
"has_exemption": false,
"start_date": "2024-12-05",
"completion_date": "2028-08-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Brigham and Women's Hospital",
"sponsor_slug": "brigham-and-womens-hospital",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06399653",
"publication_url": "https://clinicaltrials.gov/study/NCT06399653",
"title": "Non-invasive Vagal Nerve Stimulation as Novel Treatment to Improve Functional Outcomes in Veterans With Alcohol Use Disorder",
"has_exemption": false,
"start_date": "2025-01-01",
"completion_date": "2028-08-31",
"has_results": false,
"results_due": false,
"sponsor_name": "VA Office of Research and Development",
"sponsor_slug": "va-office-of-research-and-development",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06136546",
"publication_url": "https://clinicaltrials.gov/study/NCT06136546",
"title": "The Role of Inflammation in Cognitive Dysfunction in Acute Depression as Determined by Experimental Inhibition of Tumor Necrosis Factor-alpha Signaling in a Randomized Controlled Trial.",
"has_exemption": false,
"start_date": "2025-01-23",
"completion_date": "2028-08-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Massachusetts General Hospital",
"sponsor_slug": "massachusetts-general-hospital",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06785116",
"publication_url": "https://clinicaltrials.gov/study/NCT06785116",
"title": "A Randomized, Placebo-controlled Trial of DAPAgliflozin for Cardiovascular Risk Reduction in the Postpartum Period of Hypertensive Pregnancies",
"has_exemption": false,
"start_date": "2025-03-02",
"completion_date": "2028-08-31",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Michigan",
"sponsor_slug": "university-of-michigan",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06672822",
"publication_url": "https://clinicaltrials.gov/study/NCT06672822",
"title": "An Open Label Evaluation of Intralesional Injection of Sodium Thiosulfate in the Treatment of Cutaneous or Tendon Calcinosis in Connective Tissue Disease",
"has_exemption": false,
"start_date": "2025-03-17",
"completion_date": "2028-08-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Robyn T. Domsic, MD, MPH",
"sponsor_slug": "robyn-t-domsic-md-mph",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07032662",
"publication_url": "https://clinicaltrials.gov/study/NCT07032662",
"title": "A Phase 2b, Multi-center, Randomized, Double-blind, Placebo-controlled Study of IMVT-1402 Treatment in Adult Participants With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)",
"has_exemption": false,
"start_date": "2025-03-18",
"completion_date": "2028-08-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Immunovant Sciences GmbH",
"sponsor_slug": "immunovant-sciences-gmbh",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06265584",
"publication_url": "https://clinicaltrials.gov/study/NCT06265584",
"title": "Phase II Clinical Trial of 2 Step ATG Combined With Tacrolimus and Mini Methotrexate for Prevention of Acute GVHD Post Reduced Intensity Allogeneic Stem Cell Transplant",
"has_exemption": false,
"start_date": "2025-04-08",
"completion_date": "2028-08-31",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Alabama at Birmingham",
"sponsor_slug": "university-of-alabama-at-birmingham",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06943521",
"publication_url": "https://clinicaltrials.gov/study/NCT06943521",
"title": "A Phase I/II, Dose-escalation and Dose-optimization Study to Evaluate Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Efficacy of MT-4561 in Patients With Various Advanced Solid Tumors and to Evaluate Effect of MT-4561 on Pharmacokinetics of Oral Midazolam",
"has_exemption": false,
"start_date": "2025-04-18",
"completion_date": "2028-08-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Tanabe Pharma America, Inc.",
"sponsor_slug": "tanabe-pharma-america-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06939283",
"publication_url": "https://clinicaltrials.gov/study/NCT06939283",
"title": "A Phase 1b/2 Multisite Dose- and Regimen-finding and Expansion Study of WTX-330 in Adult Patients With Selected Advanced or Metastatic Solid Tumors or Non-Hodgkin Lymphoma (NHL)",
"has_exemption": false,
"start_date": "2025-05-07",
"completion_date": "2028-08-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Werewolf Therapeutics, Inc.",
"sponsor_slug": "werewolf-therapeutics-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07001800",
"publication_url": "https://clinicaltrials.gov/study/NCT07001800",
"title": "A Phase 3, Randomized, Double-Blinded, Placebo Controlled Study ChecKing the Efficacy and Safety of ATAciguat to Slow the Progression of VaLvular DYsfunction in Participants With Moderate Calcific Aortic Valve STenosis",
"has_exemption": false,
"start_date": "2025-06-27",
"completion_date": "2028-08-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Kardigan, Inc.",
"sponsor_slug": "kardigan-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06678841",
"publication_url": "https://clinicaltrials.gov/study/NCT06678841",
"title": "Randomized Trial of ELEVATEd Cardiac Pacing Rate for Personalized Treatment of Heart Failure With Preserved Ejection Fraction (ELEVATE-HFpEF)",
"has_exemption": false,
"start_date": "2025-07-09",
"completion_date": "2028-08-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Medtronic Cardiac Rhythm and Heart Failure",
"sponsor_slug": "medtronic-cardiac-rhythm-and-heart-failure",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06933329",
"publication_url": "https://clinicaltrials.gov/study/NCT06933329",
"title": "Phase 2 Study of Zelenectide Pevedotin in Participants With Previously-Treated NECTIN4 Amplified Advanced or Metastatic Non-small Cell Lung Cancer",
"has_exemption": false,
"start_date": "2025-07-18",
"completion_date": "2028-08-31",
"has_results": false,
"results_due": false,
"sponsor_name": "BicycleTx Limited",
"sponsor_slug": "bicycletx-limited",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07030699",
"publication_url": "https://clinicaltrials.gov/study/NCT07030699",
"title": "Epcoritamab With Lenalidomide and Tafasitamab in Patients With Relapsed/Refractory (R/R) Diffuse Large B Cell Lymphoma (DLBCL)",
"has_exemption": false,
"start_date": "2025-08-13",
"completion_date": "2028-08-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Memorial Sloan Kettering Cancer Center",
"sponsor_slug": "memorial-sloan-kettering-cancer-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06998407",
"publication_url": "https://clinicaltrials.gov/study/NCT06998407",
"title": "A Phase 1/2, First-in-human Study to Assess the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Antitumor Activity of AVZO-023 as a Single Agent, and in Combination With AVZO-021 and/or Endocrine Therapy in Patients With Advanced Solid Tumors",
"has_exemption": false,
"start_date": "2025-08-20",
"completion_date": "2028-08-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Avenzo Therapeutics, Inc.",
"sponsor_slug": "avenzo-therapeutics-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06965127",
"publication_url": "https://clinicaltrials.gov/study/NCT06965127",
"title": "Enhancing Walking and Independence After Incomplete SCI With a Fully Implanted Neuroprosthesis",
"has_exemption": false,
"start_date": "2025-08-27",
"completion_date": "2028-08-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Louis Stokes VA Medical Center",
"sponsor_slug": "louis-stokes-va-medical-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06813820",
"publication_url": "https://clinicaltrials.gov/study/NCT06813820",
"title": "RELIVE (Randomized Evaluation of Less Invasive Ventricular Enhancement) Trial",
"has_exemption": false,
"start_date": "2025-08-31",
"completion_date": "2028-08-31",
"has_results": false,
"results_due": false,
"sponsor_name": "BioVentrix",
"sponsor_slug": "bioventrix",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06749145",
"publication_url": "https://clinicaltrials.gov/study/NCT06749145",
"title": "Deep Learning Enhanced Detection of Aortic Stenosis - The DETECT-AS-Diagnostic Study",
"has_exemption": false,
"start_date": "2025-09-16",
"completion_date": "2028-08-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Yale University",
"sponsor_slug": "yale-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06741579",
"publication_url": "https://clinicaltrials.gov/study/NCT06741579",
"title": "Mechanisms of Stimulation for Pain Alleviation",
"has_exemption": false,
"start_date": "2025-09-26",
"completion_date": "2028-08-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Stanford University",
"sponsor_slug": "stanford-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06983470",
"publication_url": "https://clinicaltrials.gov/study/NCT06983470",
"title": "Predictive Utility and Mechanisms of Sacral Evoked Responses in Sacral Neuromodulation",
"has_exemption": false,
"start_date": "2025-09-30",
"completion_date": "2028-08-31",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Michigan",
"sponsor_slug": "university-of-michigan",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07125222",
"publication_url": "https://clinicaltrials.gov/study/NCT07125222",
"title": "Use of Gocovri to Improve Disability Due to Radiation Encephalopathy",
"has_exemption": false,
"start_date": "2025-09-30",
"completion_date": "2028-08-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Weill Medical College of Cornell University",
"sponsor_slug": "weill-medical-college-of-cornell-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06062888",
"publication_url": "https://clinicaltrials.gov/study/NCT06062888",
"title": "Multi-institutional Phase 2/3 Trial of Fresh Frozen Plasma (FFP) in Patients With Moderate to Severe Traumatic Brain Injury (TBI)",
"has_exemption": false,
"start_date": "2025-10-31",
"completion_date": "2028-08-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Northwestern University",
"sponsor_slug": "northwestern-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06957418",
"publication_url": "https://clinicaltrials.gov/study/NCT06957418",
"title": "The Alzheimer's Disease Tau Platform Clinical Trial",
"has_exemption": false,
"start_date": "2025-11-01",
"completion_date": "2028-08-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Paul S. Aisen",
"sponsor_slug": "paul-s-aisen",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07102940",
"publication_url": "https://clinicaltrials.gov/study/NCT07102940",
"title": "Eftilagimod Alpha in Combination With Neoadjuvant Chemotherapy in Patients With Hormone Receptor Positive/HER2-neg Breast Cancer",
"has_exemption": false,
"start_date": "2025-11-01",
"completion_date": "2028-08-31",
"has_results": false,
"results_due": false,
"sponsor_name": "George Washington University",
"sponsor_slug": "george-washington-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06723015",
"publication_url": "https://clinicaltrials.gov/study/NCT06723015",
"title": "Study of Tau PET Outcomes in Patients Receiving Anti-amyloid Immunotherapies",
"has_exemption": false,
"start_date": "2025-11-04",
"completion_date": "2028-08-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Mayo Clinic",
"sponsor_slug": "mayo-clinic",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07089992",
"publication_url": "https://clinicaltrials.gov/study/NCT07089992",
"title": "URSa-1: A Minibasket Study of Pembrolizumab in Ultra-Rare Sarcomas",
"has_exemption": false,
"start_date": "2025-11-11",
"completion_date": "2028-08-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Memorial Sloan Kettering Cancer Center",
"sponsor_slug": "memorial-sloan-kettering-cancer-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06943859",
"publication_url": "https://clinicaltrials.gov/study/NCT06943859",
"title": "Ketamine for the Treatment of Opioid Use Disorder",
"has_exemption": false,
"start_date": "2025-11-30",
"completion_date": "2028-08-31",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Maryland, Baltimore",
"sponsor_slug": "university-of-maryland-baltimore",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07100782",
"publication_url": "https://clinicaltrials.gov/study/NCT07100782",
"title": "Estradiol-mediated Inflammation and Central Sensitization in the Pathophysiology of Endometriosis-associated Pelvic Pain",
"has_exemption": false,
"start_date": "2025-11-30",
"completion_date": "2028-08-31",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Michigan",
"sponsor_slug": "university-of-michigan",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07167966",
"publication_url": "https://clinicaltrials.gov/study/NCT07167966",
"title": "Alzheimer's Tau Platform (ATP): Regimen Specific Appendix for AADvac1",
"has_exemption": false,
"start_date": "2025-11-30",
"completion_date": "2028-08-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Paul S. Aisen",
"sponsor_slug": "paul-s-aisen",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06957691",
"publication_url": "https://clinicaltrials.gov/study/NCT06957691",
"title": "Proof-of-Concept Trial to Assess the Efficacy and Safety of Fezolinetant in Improving Vasomotor Symptoms in Men With Prostate Cancer Undergoing Androgen Deprivation Therapy (Fezo-ADT Trial)",
"has_exemption": false,
"start_date": "2025-12-20",
"completion_date": "2028-08-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Shehzad Basaria, M.D.",
"sponsor_slug": "shehzad-basaria-md",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04056013",
"publication_url": "https://clinicaltrials.gov/study/NCT04056013",
"title": "Vicryl Rapide Versus Nonabsorbable Suture in Repair of Simple Traumatic Extremity and Trunk Lacerations in Adult Patients",
"has_exemption": false,
"start_date": "2019-09-26",
"completion_date": "2028-09-01",
"has_results": false,
"results_due": false,
"sponsor_name": "University of California, San Francisco",
"sponsor_slug": "university-of-california-san-francisco",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04140487",
"publication_url": "https://clinicaltrials.gov/study/NCT04140487",
"title": "A Phase I/II Study of Azacitidine, Venetoclax, and Gilteritinib for Patients With Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndrome With an Activating FLT3 Mutation",
"has_exemption": false,
"start_date": "2019-12-17",
"completion_date": "2028-09-01",
"has_results": false,
"results_due": false,
"sponsor_name": "M.D. Anderson Cancer Center",
"sponsor_slug": "md-anderson-cancer-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04209686",
"publication_url": "https://clinicaltrials.gov/study/NCT04209686",
"title": "Phase 2 Study of Paclitaxel, Pembrolizumab and Olaparib in Previously Treated Advanced Gastric Adenocarcinoma",
"has_exemption": false,
"start_date": "2020-07-31",
"completion_date": "2028-09-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins",
"sponsor_slug": "sidney-kimmel-comprehensive-cancer-center-at-johns-hopkins",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05100095",
"publication_url": "https://clinicaltrials.gov/study/NCT05100095",
"title": "Hypofractionated Radiation Therapy for Merkel Cell Carcinoma",
"has_exemption": false,
"start_date": "2021-12-14",
"completion_date": "2028-09-01",
"has_results": false,
"results_due": false,
"sponsor_name": "M.D. Anderson Cancer Center",
"sponsor_slug": "md-anderson-cancer-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05929729",
"publication_url": "https://clinicaltrials.gov/study/NCT05929729",
"title": "Neurovascular and Neurocognitive Consequences of Iron Deficiency Anemia",
"has_exemption": false,
"start_date": "2023-12-07",
"completion_date": "2028-09-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Children's Hospital Los Angeles",
"sponsor_slug": "childrens-hospital-los-angeles",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06027086",
"publication_url": "https://clinicaltrials.gov/study/NCT06027086",
"title": "A Phase 1b/2 Study of Glutamine Antagonist DRP-104 in Combination With Durvalumab in Patients With Advanced Stage Fibrolamellar Hepatocellular Carcinoma (FLC)",
"has_exemption": false,
"start_date": "2024-02-12",
"completion_date": "2028-09-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins",
"sponsor_slug": "sidney-kimmel-comprehensive-cancer-center-at-johns-hopkins",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04875702",
"publication_url": "https://clinicaltrials.gov/study/NCT04875702",
"title": "Treat-to-Target Serum Urate Versus Treat-to-Avoid Symptoms in Gout: A Randomized Controlled Trial",
"has_exemption": false,
"start_date": "2024-02-22",
"completion_date": "2028-09-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Massachusetts General Hospital",
"sponsor_slug": "massachusetts-general-hospital",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05919329",
"publication_url": "https://clinicaltrials.gov/study/NCT05919329",
"title": "Modulation of PSMA Expression in Castration Sensitive and Castration Resistant Prostate Cancer in Response to Hormonal Therapy",
"has_exemption": false,
"start_date": "2024-06-25",
"completion_date": "2028-09-01",
"has_results": false,
"results_due": false,
"sponsor_name": "OHSU Knight Cancer Institute",
"sponsor_slug": "ohsu-knight-cancer-institute",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06253117",
"publication_url": "https://clinicaltrials.gov/study/NCT06253117",
"title": "Evaluation of Pirfenidone as a Novel Therapeutic Strategy Against Recurrent Acute Pancreatitis.",
"has_exemption": false,
"start_date": "2024-06-27",
"completion_date": "2028-09-01",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Alabama at Birmingham",
"sponsor_slug": "university-of-alabama-at-birmingham",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06573996",
"publication_url": "https://clinicaltrials.gov/study/NCT06573996",
"title": "The Effect of Intraoral Transcutaneous Electrical Nerve Stimulation (TENS) on Pain Perception During Orthodontic Alignment and Leveling: a Randomized Clinical Trial",
"has_exemption": false,
"start_date": "2024-09-16",
"completion_date": "2028-09-01",
"has_results": false,
"results_due": false,
"sponsor_name": "University of the Pacific",
"sponsor_slug": "university-of-the-pacific",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06415591",
"publication_url": "https://clinicaltrials.gov/study/NCT06415591",
"title": "Auricular Neuromodulation in Veterans With Fibromyalgia: A Randomized, Sham-Controlled Study",
"has_exemption": false,
"start_date": "2024-11-01",
"completion_date": "2028-09-01",
"has_results": false,
"results_due": false,
"sponsor_name": "VA Office of Research and Development",
"sponsor_slug": "va-office-of-research-and-development",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06567314",
"publication_url": "https://clinicaltrials.gov/study/NCT06567314",
"title": "Phase 2 Study of Ivonescimab in Patients With Cutaneous Squamous Cell Carcinoma",
"has_exemption": false,
"start_date": "2024-12-02",
"completion_date": "2028-09-01",
"has_results": false,
"results_due": false,
"sponsor_name": "M.D. Anderson Cancer Center",
"sponsor_slug": "md-anderson-cancer-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06883162",
"publication_url": "https://clinicaltrials.gov/study/NCT06883162",
"title": "Randomized Controlled Trial of Varenicline to Treat Tobacco and Cannabis Co-Use (RECLAIM)",
"has_exemption": false,
"start_date": "2025-05-06",
"completion_date": "2028-09-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Medical University of South Carolina",
"sponsor_slug": "medical-university-of-south-carolina",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06651593",
"publication_url": "https://clinicaltrials.gov/study/NCT06651593",
"title": "Phase II Biomarker Study of SAR444881 in Combination With Cemiplimab in Solid Tumors",
"has_exemption": false,
"start_date": "2025-07-02",
"completion_date": "2028-09-01",
"has_results": false,
"results_due": false,
"sponsor_name": "M.D. Anderson Cancer Center",
"sponsor_slug": "md-anderson-cancer-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07105709",
"publication_url": "https://clinicaltrials.gov/study/NCT07105709",
"title": "A Multi-Centre, Single Arm, Open-Label Extension Study to Evaluate the Long-term Safety and Efficacy of GSK4527226 (AL101) in Participants With Early Alzheimer's Disease",
"has_exemption": false,
"start_date": "2025-08-14",
"completion_date": "2028-09-01",
"has_results": false,
"results_due": false,
"sponsor_name": "GlaxoSmithKline",
"sponsor_slug": "glaxosmithkline",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07103616",
"publication_url": "https://clinicaltrials.gov/study/NCT07103616",
"title": "Individual Cerebral Hemodynamic Oxygenation Relationships - ICHOR 4",
"has_exemption": false,
"start_date": "2025-09-01",
"completion_date": "2028-09-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Children's Hospital Los Angeles",
"sponsor_slug": "childrens-hospital-los-angeles",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07016399",
"publication_url": "https://clinicaltrials.gov/study/NCT07016399",
"title": "A Phase II Neoadjuvant Clinical Trial of the Androgen Receptor Inhibitor Darolutamide in Early-Stage Androgen Receptor Positive (AR+) Triple-Negative Breast Cancer",
"has_exemption": false,
"start_date": "2025-09-09",
"completion_date": "2028-09-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Vandana Abramson",
"sponsor_slug": "vandana-abramson",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07113743",
"publication_url": "https://clinicaltrials.gov/study/NCT07113743",
"title": "Part B- Phase I/II, Non-Randomized, Single Site Study, Open-label Study of G1XCGD (Lentiviral Vector Transduced CD34+ Cells) in Patients With X-Linked Chronic Granulomatous Disease",
"has_exemption": false,
"start_date": "2025-09-10",
"completion_date": "2028-09-01",
"has_results": false,
"results_due": false,
"sponsor_name": "National Institute of Allergy and Infectious Diseases (NIAID)",
"sponsor_slug": "national-institute-of-allergy-and-infectious-diseases-niaid",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07221942",
"publication_url": "https://clinicaltrials.gov/study/NCT07221942",
"title": "Pembrolizumab Maintenance After Enfortumab Vedotin/Pembrolizumab Induction in Front-Line Metastatic Urothelial Carcinoma",
"has_exemption": false,
"start_date": "2026-01-31",
"completion_date": "2028-09-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Fox Chase Cancer Center",
"sponsor_slug": "fox-chase-cancer-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06758401",
"publication_url": "https://clinicaltrials.gov/study/NCT06758401",
"title": "AN OPEN-LABEL, RANDOMIZED, CONTROLLED PHASE 3 STUDY OF SIGVOTATUG VEDOTIN IN COMBINATION WITH PEMBROLIZUMAB COMPARED WITH PEMBROLIZUMAB MONOTHERAPY AS FIRST-LINE TREATMENT IN PARTICIPANTS WITH PD-L1 HIGH (≥50% OF TUMOR CELLS EXPRESSING PD-L1), LOCALLY ADVANCED, UNRESECTABLE, OR METASTATIC NON-SMALL CELL LUNG CANCER (BE6A LUNG-02)",
"has_exemption": false,
"start_date": "2025-07-23",
"completion_date": "2028-09-05",
"has_results": false,
"results_due": false,
"sponsor_name": "Pfizer",
"sponsor_slug": "pfizer",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05599360",
"publication_url": "https://clinicaltrials.gov/study/NCT05599360",
"title": "Vyxeos for Induction of Newly Diagnosed Low- or Intermediate-risk AML Patients, Age 18-70. A Pilot Study",
"has_exemption": false,
"start_date": "2022-08-07",
"completion_date": "2028-09-07",
"has_results": false,
"results_due": false,
"sponsor_name": "Shaare Zedek Medical Center",
"sponsor_slug": "shaare-zedek-medical-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06963827",
"publication_url": "https://clinicaltrials.gov/study/NCT06963827",
"title": "A Phase 3 Multicenter, Randomized, Double-Blind, Placebo Controlled Trial to Evaluate Efficacy and Safety of Mezagitamab (TAK-079) in Study Participants With Primary IgA Nephropathy in Combination With Stable Background Therapy",
"has_exemption": false,
"start_date": "2025-07-15",
"completion_date": "2028-09-07",
"has_results": false,
"results_due": false,
"sponsor_name": "Takeda",
"sponsor_slug": "takeda",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05611801",
"publication_url": "https://clinicaltrials.gov/study/NCT05611801",
"title": "AN OPEN-LABEL STUDY IN PEDIATRIC (<18 YEARS OF AGE), SEVERE HEMOPHILIA A PARTICIPANTS (COAGULATION FACTOR ACTIVITY <1%) WITH OR WITHOUT INHIBITORS OR MODERATELY SEVERE TO SEVERE HEMOPHILIA B PARTICIPANTS (COAGULATION FACTOR ACTIVITY =2%) WITH OR WITHOUT INHIBITORS COMPARING 12 MONTHS OF HISTORICAL STANDARD TREATMENT TO MARSTACIMAB PROPHYLAXIS",
"has_exemption": false,
"start_date": "2022-12-09",
"completion_date": "2028-09-10",
"has_results": false,
"results_due": false,
"sponsor_name": "Pfizer",
"sponsor_slug": "pfizer",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06959641",
"publication_url": "https://clinicaltrials.gov/study/NCT06959641",
"title": "A Phase 2 Open Label Study of XL092 as First Line Therapy in Radioiodine Refractory Differentiated Thyroid Cancer",
"has_exemption": false,
"start_date": "2025-06-06",
"completion_date": "2028-09-11",
"has_results": false,
"results_due": false,
"sponsor_name": "Northwestern University",
"sponsor_slug": "northwestern-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06976216",
"publication_url": "https://clinicaltrials.gov/study/NCT06976216",
"title": "A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Efficacy and Safety of KarXT + KarX-EC for the Treatment of Cognitive Impairment Associated With Mild to Moderate Alzheimer's Disease (MINDSET 1)",
"has_exemption": false,
"start_date": "2025-07-14",
"completion_date": "2028-09-11",
"has_results": false,
"results_due": false,
"sponsor_name": "Bristol-Myers Squibb",
"sponsor_slug": "bristol-myers-squibb",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06976203",
"publication_url": "https://clinicaltrials.gov/study/NCT06976203",
"title": "A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Efficacy and Safety of KarXT + KarX-EC for the Treatment of Cognitive Impairment Associated With Mild to Moderate Alzheimer's Disease (MINDSET 2)",
"has_exemption": false,
"start_date": "2025-07-21",
"completion_date": "2028-09-11",
"has_results": false,
"results_due": false,
"sponsor_name": "Bristol-Myers Squibb",
"sponsor_slug": "bristol-myers-squibb",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06980480",
"publication_url": "https://clinicaltrials.gov/study/NCT06980480",
"title": "A Multicenter, Randomized, Controlled, Open-label, Group-Sequential, Phase 3 Study to Investigate the Efficacy, Safety, and Tolerability of Intravenous Gammagard Liquid (Immune Globulin Infusion, 10%) for Primary Infection Prophylaxis Compared With Secondary Infection Prophylaxis in Adult Subjects With Multiple Myeloma Receiving B-Cell Maturation AntigenxCD3-Directed Bispecific Antibody Therapy",
"has_exemption": false,
"start_date": "2025-11-29",
"completion_date": "2028-09-11",
"has_results": false,
"results_due": false,
"sponsor_name": "Takeda",
"sponsor_slug": "takeda",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06305754",
"publication_url": "https://clinicaltrials.gov/study/NCT06305754",
"title": "A Randomized, Open-label, Phase 3 Study of MK-2870 vs. Platinum Doublets in Participants With EGFR-mutated, Advanced Nonsquamous Non-small Cell Lung Cancer (NSCLC) Who Have Progressed on Prior EGFR Tyrosine Kinase Inhibitors",
"has_exemption": false,
"start_date": "2024-06-11",
"completion_date": "2028-09-12",
"has_results": false,
"results_due": false,
"sponsor_name": "Merck Sharp & Dohme LLC",
"sponsor_slug": "merck-sharp-dohme-llc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07028853",
"publication_url": "https://clinicaltrials.gov/study/NCT07028853",
"title": "A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of Mevrometostat (PF-06821497) With Enzalutamide in Metastatic Castration-Sensitive Prostate Cancer (MEVPRO-3)",
"has_exemption": false,
"start_date": "2025-09-28",
"completion_date": "2028-09-12",
"has_results": false,
"results_due": false,
"sponsor_name": "Pfizer",
"sponsor_slug": "pfizer",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06847542",
"publication_url": "https://clinicaltrials.gov/study/NCT06847542",
"title": "A Phase IIIb, Multicenter, Single-arm Study Assessing the Effectiveness, Safety and Patient Reported Outcomes of a 36-week Refill Exchange Regimen for the Port Delivery System With Ranibizumab in Patients With Neovascular Age-related Macular Degeneration",
"has_exemption": false,
"start_date": "2025-11-27",
"completion_date": "2028-09-12",
"has_results": false,
"results_due": false,
"sponsor_name": "Hoffmann-La Roche",
"sponsor_slug": "hoffmann-la-roche",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05244486",
"publication_url": "https://clinicaltrials.gov/study/NCT05244486",
"title": "Efficacy of RestoreX Penile Traction Therapy In Preserving Erectile Function Post-Prostatectomy",
"has_exemption": false,
"start_date": "2022-03-12",
"completion_date": "2028-09-14",
"has_results": false,
"results_due": false,
"sponsor_name": "Charitable Union for the Research and Education of Peyronie's Disease",
"sponsor_slug": "charitable-union-for-the-research-and-education-of-peyronies-disease",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06872892",
"publication_url": "https://clinicaltrials.gov/study/NCT06872892",
"title": "A Phase III, Randomised, Double-blind, Placebo-controlled Study to Assess the Efficacy, Safety, and Tolerability of BI 1291583 2.5 mg Administered Once Daily for up to 76 Weeks in Patients With Bronchiectasis (The AIRTIVITY™ Study)",
"has_exemption": false,
"start_date": "2025-06-09",
"completion_date": "2028-09-14",
"has_results": false,
"results_due": false,
"sponsor_name": "Boehringer Ingelheim",
"sponsor_slug": "boehringer-ingelheim",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07094516",
"publication_url": "https://clinicaltrials.gov/study/NCT07094516",
"title": "A Randomized, Placebo-controlled, Parallel Group, 72-week Study to Evaluate the Efficacy and Safety of VHB937 in Participants With Early Alzheimer's Disease Followed by an Extension",
"has_exemption": false,
"start_date": "2025-08-07",
"completion_date": "2028-09-14",
"has_results": false,
"results_due": false,
"sponsor_name": "Novartis Pharmaceuticals",
"sponsor_slug": "novartis-pharmaceuticals",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06175000",
"publication_url": "https://clinicaltrials.gov/study/NCT06175000",
"title": "Maintenance Obinutuzumab for Primary Central Nervous System Lymphoma Complete or Partial Responders",
"has_exemption": false,
"start_date": "2024-03-13",
"completion_date": "2028-09-15",
"has_results": false,
"results_due": false,
"sponsor_name": "Providence Health & Services",
"sponsor_slug": "providence-health-services",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06158828",
"publication_url": "https://clinicaltrials.gov/study/NCT06158828",
"title": "A Phase I/II Pilot Study of Memory-like NK Cells to Consolidate TCRαβ T Cell Depleted Haploidentical Transplant in High-risk AML",
"has_exemption": false,
"start_date": "2024-05-15",
"completion_date": "2028-09-15",
"has_results": false,
"results_due": false,
"sponsor_name": "Washington University School of Medicine",
"sponsor_slug": "washington-university-school-of-medicine",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06514547",
"publication_url": "https://clinicaltrials.gov/study/NCT06514547",
"title": "Vaccine Immunity and Inflammation in the Aging Person Living With HIV",
"has_exemption": false,
"start_date": "2024-07-08",
"completion_date": "2028-09-15",
"has_results": false,
"results_due": false,
"sponsor_name": "Hennepin Healthcare Research Institute.",
"sponsor_slug": "hennepin-healthcare-research-institute",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06570798",
"publication_url": "https://clinicaltrials.gov/study/NCT06570798",
"title": "A Phase 2a, Open Label, Multicenter, Platform Trial to Assess the Safety, Tolerability, and Efficacy of Inebilizumab and Blinatumomab in Subjects With Autoimmune Diseases",
"has_exemption": false,
"start_date": "2025-07-16",
"completion_date": "2028-09-15",
"has_results": false,
"results_due": false,
"sponsor_name": "Amgen",
"sponsor_slug": "amgen",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07100080",
"publication_url": "https://clinicaltrials.gov/study/NCT07100080",
"title": "IZABRIGHT-Lung01: A Randomized, Open-label, Phase 2/3 Study of Izalontamab Brengitecan (BMS-986507) Versus Platinum-based Chemotherapy in Patients With EGFR-mutated Non-small Cell Lung Cancer and Disease Progression on EGFR Tyrosine Kinase Inhibitor Therapy",
"has_exemption": false,
"start_date": "2025-11-05",
"completion_date": "2028-09-15",
"has_results": false,
"results_due": false,
"sponsor_name": "Bristol-Myers Squibb",
"sponsor_slug": "bristol-myers-squibb",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07015996",
"publication_url": "https://clinicaltrials.gov/study/NCT07015996",
"title": "Efficacy of Tezepelumab in Peanut Oral Immunotherapy: a Double-Blind, Randomized, Placebo-Controlled Trial",
"has_exemption": false,
"start_date": "2026-02-18",
"completion_date": "2028-09-16",
"has_results": false,
"results_due": false,
"sponsor_name": "National Institute of Allergy and Infectious Diseases (NIAID)",
"sponsor_slug": "national-institute-of-allergy-and-infectious-diseases-niaid",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06990529",
"publication_url": "https://clinicaltrials.gov/study/NCT06990529",
"title": "An Open-label, Single-arm Extension Study to Evaluate the Long-term Safety, Tolerability, and Efficacy of Leniolisib for Immune Dysregulation in Primary Immunodeficiency Disorders",
"has_exemption": false,
"start_date": "2025-04-29",
"completion_date": "2028-09-18",
"has_results": false,
"results_due": false,
"sponsor_name": "Pharming Technologies B.V.",
"sponsor_slug": "pharming-technologies-bv",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07228403",
"publication_url": "https://clinicaltrials.gov/study/NCT07228403",
"title": "A 104-week, Multicenter, Open-label, Single-arm, Phase 3 Extension Trial Investigating the Long-term Safety and Efficacy of Glepaglutide in Adult Patients With Short Bowel Syndrome (SBS) Rolling Over From the EASE SBS 2 or 3 Trials",
"has_exemption": false,
"start_date": "2025-11-25",
"completion_date": "2028-09-18",
"has_results": false,
"results_due": false,
"sponsor_name": "Zealand Pharma",
"sponsor_slug": "zealand-pharma",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04889430",
"publication_url": "https://clinicaltrials.gov/study/NCT04889430",
"title": "A Multicenter, Single-arm, Open Label Trial to Evaluate Efficacy and Safety of Oral, Twice Daily LNP023 in Adult aHUS Patients Who Are Naive to Complement Inhibitor Therapy",
"has_exemption": false,
"start_date": "2022-01-17",
"completion_date": "2028-09-19",
"has_results": false,
"results_due": false,
"sponsor_name": "Novartis Pharmaceuticals",
"sponsor_slug": "novartis-pharmaceuticals",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05239741",
"publication_url": "https://clinicaltrials.gov/study/NCT05239741",
"title": "A Phase 3 Study of Pembrolizumab (MK-3475) Versus Chemotherapy in Chinese Participants With Stage IV Microsatellite Instability-High (MSI-H) or Mismatch Repair Deficient (dMMR) Colorectal Cancer (MK-3475-C66)",
"has_exemption": false,
"start_date": "2022-04-02",
"completion_date": "2028-09-19",
"has_results": false,
"results_due": false,
"sponsor_name": "Merck Sharp & Dohme LLC",
"sponsor_slug": "merck-sharp-dohme-llc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07196722",
"publication_url": "https://clinicaltrials.gov/study/NCT07196722",
"title": "A Phase 2b/3 Randomized, Double-blind, Placebo-Controlled, Parallel Group, Multicenter Protocol to Evaluate the Efficacy and Safety of Icotrokinra in Participants With Moderately to Severely Active Crohn's Disease",
"has_exemption": false,
"start_date": "2025-10-03",
"completion_date": "2028-09-19",
"has_results": false,
"results_due": false,
"sponsor_name": "Janssen Research & Development, LLC",
"sponsor_slug": "janssen-research-development-llc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05587712",
"publication_url": "https://clinicaltrials.gov/study/NCT05587712",
"title": "A Phase 2 Open-label Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Sotatercept (MK-7962) in Children From 1 to Less Than 18 Years of Age With PAH on Standard of Care",
"has_exemption": false,
"start_date": "2023-01-19",
"completion_date": "2028-09-21",
"has_results": false,
"results_due": false,
"sponsor_name": "Merck Sharp & Dohme LLC",
"sponsor_slug": "merck-sharp-dohme-llc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06057935",
"publication_url": "https://clinicaltrials.gov/study/NCT06057935",
"title": "ICARuS II (Intraperitoneal Chemotherapy After cytoReductive Surgery): A Multicenter, Randomized Phase II Trial of Normothermic Intraperitoneal Chemotherapy and Intravenous Chemotherapy After Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Malignant Peritoneal Mesothelioma",
"has_exemption": false,
"start_date": "2023-09-21",
"completion_date": "2028-09-21",
"has_results": false,
"results_due": false,
"sponsor_name": "Memorial Sloan Kettering Cancer Center",
"sponsor_slug": "memorial-sloan-kettering-cancer-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06799000",
"publication_url": "https://clinicaltrials.gov/study/NCT06799000",
"title": "A Randomized, Double-blind, Double-dummy, Placebo-controlled, Multicenter, Phase 3 Study Assessing the Efficacy, Safety, and Tolerability of 2 Doses of Remibrutinib Over a 68-week Treatment Period in Adult Patients With Moderate to Severe Hidradenitis Suppurativa.",
"has_exemption": false,
"start_date": "2025-01-31",
"completion_date": "2028-09-21",
"has_results": false,
"results_due": false,
"sponsor_name": "Novartis Pharmaceuticals",
"sponsor_slug": "novartis-pharmaceuticals",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07185009",
"publication_url": "https://clinicaltrials.gov/study/NCT07185009",
"title": "A Multicenter, Multinational, Randomized, Double-blind, Placebo-Controlled, Phase 3 Maintenance Study to Evaluate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Ulcerative Colitis",
"has_exemption": false,
"start_date": "2026-01-07",
"completion_date": "2028-09-21",
"has_results": false,
"results_due": false,
"sponsor_name": "Sanofi",
"sponsor_slug": "sanofi",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT01499888",
"publication_url": "https://clinicaltrials.gov/study/NCT01499888",
"title": "Phase I/II Study of Allogeneic Stem Cell Transplantation to Treat Clinically Aggressive Sickle Cell Disease (SCD)",
"has_exemption": false,
"start_date": "2011-11-11",
"completion_date": "2028-09-23",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Illinois at Chicago",
"sponsor_slug": "university-of-illinois-at-chicago",
"status": "ongoing",
"is_pact": true,
"days_late": null
},
{
"registry_id": "NCT06882785",
"publication_url": "https://clinicaltrials.gov/study/NCT06882785",
"title": "A Phase 3, Randomized, Two-part Study With a 5-week Double-blind Part (Randomized, Parallelgroup, Placebo-controlled) Followed by a 52-week Open-label Extension Part to Evaluate the Efficacy and Safety of KarXT in Acutely Psychotic Japanese Adult Patients With Diagnostic and Statistical Manual of Mental Disorders-Fifth Edition (DSM-5) Schizophrenia",
"has_exemption": false,
"start_date": "2025-06-10",
"completion_date": "2028-09-23",
"has_results": false,
"results_due": false,
"sponsor_name": "Bristol-Myers Squibb",
"sponsor_slug": "bristol-myers-squibb",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06726148",
"publication_url": "https://clinicaltrials.gov/study/NCT06726148",
"title": "An Open-label, Multi-center, Phase I/II Study of ECI830 as a Single Agent and in Combination With Ribociclib and Endocrine Therapy in Patients With Advanced Hormone Receptor Positive, HER2-negative Breast Cancer and Advanced Solid Tumors",
"has_exemption": false,
"start_date": "2025-04-03",
"completion_date": "2028-09-25",
"has_results": false,
"results_due": false,
"sponsor_name": "Novartis Pharmaceuticals",
"sponsor_slug": "novartis-pharmaceuticals",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06435429",
"publication_url": "https://clinicaltrials.gov/study/NCT06435429",
"title": "A Phase 3, Randomized, Open-label, Multicenter, Controlled Study to Evaluate the Efficacy and Safety of Zanidatamab in Combination With Physician's Choice Chemotherapy Compared to Trastuzumab in Combination With Physician's Choice Chemotherapy for the Treatment of Participants With Metastatic HER2-positive Breast Cancer Who Have Progressed on, or Are Intolerant to, Previous Trastuzumab Deruxtecan Treatment",
"has_exemption": false,
"start_date": "2024-08-13",
"completion_date": "2028-09-26",
"has_results": false,
"results_due": false,
"sponsor_name": "Jazz Pharmaceuticals",
"sponsor_slug": "jazz-pharmaceuticals",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06687603",
"publication_url": "https://clinicaltrials.gov/study/NCT06687603",
"title": "Multi-Site Detection of Barrett's Esophagus in Patients Without Chronic GERD Symptoms",
"has_exemption": false,
"start_date": "2025-03-10",
"completion_date": "2028-09-27",
"has_results": false,
"results_due": false,
"sponsor_name": "Case Comprehensive Cancer Center",
"sponsor_slug": "case-comprehensive-cancer-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07213609",
"publication_url": "https://clinicaltrials.gov/study/NCT07213609",
"title": "A Phase 1/2 Open-label, Multicenter Study of Oral GSK5460025 Alone or in Combination With Other Anti-cancer Agents in Adult Participants With Mismatch Repair-deficient (dMMR) or Microsatellite Instability-High (MSI-H) Solid Tumors",
"has_exemption": false,
"start_date": "2025-10-20",
"completion_date": "2028-09-28",
"has_results": false,
"results_due": false,
"sponsor_name": "GlaxoSmithKline",
"sponsor_slug": "glaxosmithkline",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06143891",
"publication_url": "https://clinicaltrials.gov/study/NCT06143891",
"title": "A Randomized, Double-blind, Multicenter, Phase 3 Study to Evaluate Efficacy and Safety of Belumosudil in Combination With Corticosteroids Versus Placebo in Combination With Corticosteroids in Participants at Least 12 Years of Age With Newly Diagnosed Chronic Graft Versus Host Disease (cGVHD)",
"has_exemption": false,
"start_date": "2024-01-23",
"completion_date": "2028-09-29",
"has_results": false,
"results_due": false,
"sponsor_name": "Sanofi",
"sponsor_slug": "sanofi",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06134362",
"publication_url": "https://clinicaltrials.gov/study/NCT06134362",
"title": "A Phase IIIB, Long-Term Follow-Up of CAB LA for Participants in HPTN 083 and HPTN 084 CAB PrEP Studies at Risk of HIV Acquisition",
"has_exemption": false,
"start_date": "2024-05-24",
"completion_date": "2028-09-29",
"has_results": false,
"results_due": false,
"sponsor_name": "ViiV Healthcare",
"sponsor_slug": "viiv-healthcare",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT01697371",
"publication_url": "https://clinicaltrials.gov/study/NCT01697371",
"title": "Phase I-II Trial of Stereotactic Body Proton Therapy for Patients With Liver Metastases",
"has_exemption": false,
"start_date": "2012-08-22",
"completion_date": "2028-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Loma Linda University",
"sponsor_slug": "loma-linda-university",
"status": "ongoing",
"is_pact": true,
"days_late": null
},
{
"registry_id": "NCT01912651",
"publication_url": "https://clinicaltrials.gov/study/NCT01912651",
"title": "The Role of Antibiotics in Full Thickness Skin Graft Survival for Facial Reconstructive Surgery",
"has_exemption": false,
"start_date": "2013-07-31",
"completion_date": "2028-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Michigan",
"sponsor_slug": "university-of-michigan",
"status": "ongoing",
"is_pact": true,
"days_late": null
},
{
"registry_id": "NCT02796937",
"publication_url": "https://clinicaltrials.gov/study/NCT02796937",
"title": "An Open-Label, Multicenter Study to Evaluate the Long-term Safety of Weekly Intravenous Alpha1-Proteinase Inhibitor (Human), Modified Process 60 mg/kg in Subjects With Pulmonary Emphysema Due to Alpha1-Antitrypsin Deficiency",
"has_exemption": false,
"start_date": "2016-07-31",
"completion_date": "2028-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Grifols Therapeutics LLC",
"sponsor_slug": "grifols-therapeutics-llc",
"status": "ongoing",
"is_pact": true,
"days_late": null
},
{
"registry_id": "NCT03398135",
"publication_url": "https://clinicaltrials.gov/study/NCT03398135",
"title": "A Multicenter, Randomized, Double-Blind, Placebo Controlled 52-Week Maintenance and an Open-Label Extension Study of the Efficacy and Safety of Risankizumab in Subjects With Ulcerative Colitis",
"has_exemption": false,
"start_date": "2018-08-28",
"completion_date": "2028-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "AbbVie",
"sponsor_slug": "abbvie",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT03900468",
"publication_url": "https://clinicaltrials.gov/study/NCT03900468",
"title": "Medtronic Deep Brain Stimulation (DBS) Therapy for Epilepsy Post-Approval Study (EPAS)",
"has_exemption": false,
"start_date": "2020-03-05",
"completion_date": "2028-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "MedtronicNeuro",
"sponsor_slug": "medtronicneuro",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04375033",
"publication_url": "https://clinicaltrials.gov/study/NCT04375033",
"title": "CSP #2014 - Comparative Effectiveness of Two Formulations of Buprenorphine for Treating Opioid Use Disorder in Veterans (VA-BRAVE)",
"has_exemption": false,
"start_date": "2020-11-03",
"completion_date": "2028-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "VA Office of Research and Development",
"sponsor_slug": "va-office-of-research-and-development",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04663347",
"publication_url": "https://clinicaltrials.gov/study/NCT04663347",
"title": "A Phase 1b/2, Open-Label Trial to Assess the Safety and Preliminary Efficacy of Epcoritamab (GEN3013; DuoBody®-CD3xCD20) in Combination With Other Agents in Subjects With B-cell Non-Hodgkin Lymphoma (B-NHL)",
"has_exemption": false,
"start_date": "2020-11-03",
"completion_date": "2028-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Genmab",
"sponsor_slug": "genmab",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04545736",
"publication_url": "https://clinicaltrials.gov/study/NCT04545736",
"title": "Oral Metformin for Treatment of ABCA4 Retinopathy",
"has_exemption": false,
"start_date": "2020-11-23",
"completion_date": "2028-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "National Eye Institute (NEI)",
"sponsor_slug": "national-eye-institute-nei",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04535271",
"publication_url": "https://clinicaltrials.gov/study/NCT04535271",
"title": "TAGGED: A Phase 2 Study Using Low Dose/Metronomic Trabectedin, Gemcitabine, and Dacarbazine as 2nd/3rd/4th Line Therapy for Advanced Soft Tissue Sarcoma",
"has_exemption": false,
"start_date": "2021-09-09",
"completion_date": "2028-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Sarcoma Oncology Research Center, LLC",
"sponsor_slug": "sarcoma-oncology-research-center-llc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04914507",
"publication_url": "https://clinicaltrials.gov/study/NCT04914507",
"title": "A Prospective Analysis of Long-Term Clinical Outcomes and 3D Spine Growth in Anterior Vertebral Body Tethering",
"has_exemption": false,
"start_date": "2021-09-09",
"completion_date": "2028-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Pediatric Spine Foundation",
"sponsor_slug": "pediatric-spine-foundation",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04526938",
"publication_url": "https://clinicaltrials.gov/study/NCT04526938",
"title": "Clinical Outcomes, Radiation Dosage, and Quality of Life in Patients Treated With Fenestrated Stent Grafts for Complex Thoracoabdominal and Abdominal Aortic Aneurysms, Thoracoabdominal Aortic Aneurysms Secondary to Aortic Dissections",
"has_exemption": false,
"start_date": "2021-09-20",
"completion_date": "2028-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Medstar Health Research Institute",
"sponsor_slug": "medstar-health-research-institute",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04372615",
"publication_url": "https://clinicaltrials.gov/study/NCT04372615",
"title": "A Phase-2b, Double-Blind, Randomized Controlled Trial to Evaluate the Activity and Safety of Inebilizumab in Anti-Nmda Receptor Encephalitis and Assess Markers of Disease",
"has_exemption": false,
"start_date": "2022-03-30",
"completion_date": "2028-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Utah",
"sponsor_slug": "university-of-utah",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05197881",
"publication_url": "https://clinicaltrials.gov/study/NCT05197881",
"title": "Daily Adaptive External Beam Radiation Therapy in the Treatment of Carcinoma of the Cervix: A Prospective Trial of an Individualized Approach for Intestinal Toxicity Reduction (ARTIA-Cervix)",
"has_exemption": false,
"start_date": "2022-05-03",
"completion_date": "2028-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Varian, a Siemens Healthineers Company",
"sponsor_slug": "varian-a-siemens-healthineers-company",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05613413",
"publication_url": "https://clinicaltrials.gov/study/NCT05613413",
"title": "LUNG-IST-127: a Pilot Phase II Study of Maintenance Cabozantinib Plus Pembrolizumab (CP) for Patients with Metastatic SqNSCLC with Disease Control Following Induction Therapy",
"has_exemption": false,
"start_date": "2022-12-28",
"completion_date": "2028-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Illinois at Chicago",
"sponsor_slug": "university-of-illinois-at-chicago",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05765812",
"publication_url": "https://clinicaltrials.gov/study/NCT05765812",
"title": "A Phase 1/2 Open-label Study of Debio 0123 in Combination With Temozolomide in Adult Participants With Recurrent or Progressive Glioblastoma and of Debio 0123 in Combination With Temozolomide and Radiotherapy in Adult Participants With Newly Diagnosed Glioblastoma",
"has_exemption": false,
"start_date": "2023-05-15",
"completion_date": "2028-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Debiopharm International SA",
"sponsor_slug": "debiopharm-international-sa",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05941052",
"publication_url": "https://clinicaltrials.gov/study/NCT05941052",
"title": "Supporting, Mobilizing and Accelerating Research for Tuberculosis Elimination (SMART4TB)- Technical Area (TA) 1: Diagnostics- Assessing Diagnostics At Point-of-care for Tuberculosis (ADAPT)",
"has_exemption": false,
"start_date": "2023-08-28",
"completion_date": "2028-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "University of California, San Francisco",
"sponsor_slug": "university-of-california-san-francisco",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05979441",
"publication_url": "https://clinicaltrials.gov/study/NCT05979441",
"title": "A Phase 3, Single-Arm, Multicenter, Open-label Extension of Study ARGX-113-2007 to Investigate the Long-term Safety, Tolerability, and Efficacy of Efgartigimod PH20 SC in Participants Aged 18 Years and Older With Active Idiopathic Inflammatory Myopathy",
"has_exemption": false,
"start_date": "2023-09-12",
"completion_date": "2028-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "argenx",
"sponsor_slug": "argenx",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05934487",
"publication_url": "https://clinicaltrials.gov/study/NCT05934487",
"title": "A Prospective, Multi-Center, Open Label, Randomized Control Clinical Trial Evaluating the Safety and Efficacy of the Cordella™ Pulmonary Artery Sensor System in New York Heart Association (NYHA) Class II-III Heart Failure Patients",
"has_exemption": false,
"start_date": "2023-11-29",
"completion_date": "2028-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Endotronix, Inc.",
"sponsor_slug": "endotronix-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06056583",
"publication_url": "https://clinicaltrials.gov/study/NCT06056583",
"title": "Postpartum Activity and Expression of BCRP and OCT1 Drug Transporters in the Mammary Gland",
"has_exemption": false,
"start_date": "2023-12-04",
"completion_date": "2028-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Washington",
"sponsor_slug": "university-of-washington",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05828069",
"publication_url": "https://clinicaltrials.gov/study/NCT05828069",
"title": "Phase 2 Study of Tovorafenib (DAY101) in Relapsed and Refractory Langerhans Cell Histiocytosis",
"has_exemption": false,
"start_date": "2024-03-28",
"completion_date": "2028-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "National Cancer Institute (NCI)",
"sponsor_slug": "national-cancer-institute-nci",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06128356",
"publication_url": "https://clinicaltrials.gov/study/NCT06128356",
"title": "Pilot Study of Dexmedetomidine Sublingual Film for the Ambulatory Treatment of Hyperadrenergic Autonomic Crisis in Patients With Familial Dysautonomia",
"has_exemption": false,
"start_date": "2024-06-01",
"completion_date": "2028-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "NYU Langone Health",
"sponsor_slug": "nyu-langone-health",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06564142",
"publication_url": "https://clinicaltrials.gov/study/NCT06564142",
"title": "A Phase 3, Randomized, Double-blind, Placebo-controlled Study of Povetacicept in Adults With Immunoglobulin A Nephropathy (RAINIER)",
"has_exemption": false,
"start_date": "2024-08-30",
"completion_date": "2028-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Alpine Immune Sciences Inc, A Subsidiary of Vertex",
"sponsor_slug": "alpine-immune-sciences-inc-a-subsidiary-of-vertex",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06464692",
"publication_url": "https://clinicaltrials.gov/study/NCT06464692",
"title": "A Phase 1b Study to Evaluate Safety and Pharmacokinetics (PK) of Telisotuzumab Adizutecan (ABBV-400) in Chinese Subjects With Unresectable Locally Advanced/Metastatic Colorectal Cancer",
"has_exemption": false,
"start_date": "2024-09-30",
"completion_date": "2028-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "AbbVie",
"sponsor_slug": "abbvie",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06782516",
"publication_url": "https://clinicaltrials.gov/study/NCT06782516",
"title": "Native-RISE (Risk Identification for Suicide and Enhanced Care)",
"has_exemption": false,
"start_date": "2024-12-01",
"completion_date": "2028-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Johns Hopkins Bloomberg School of Public Health",
"sponsor_slug": "johns-hopkins-bloomberg-school-of-public-health",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06083480",
"publication_url": "https://clinicaltrials.gov/study/NCT06083480",
"title": "Reducing Perioperative Oxidative Stress to Prevent Postoperative Chronic Pain Following Total Knee Arthroplasty",
"has_exemption": false,
"start_date": "2024-12-06",
"completion_date": "2028-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Vanderbilt University Medical Center",
"sponsor_slug": "vanderbilt-university-medical-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06463028",
"publication_url": "https://clinicaltrials.gov/study/NCT06463028",
"title": "An Open-label, Multi-Center, Phase 2 Clinical Trial Evaluating Sapanisertib and Serabelisib (PIKTOR) With Paclitaxel, and a Substudy Evaluating PIKTOR With Paclitaxel Plus an Insulin-Suppressing Diet, in Patients With Advanced or Recurrent Endometrial Cancer",
"has_exemption": false,
"start_date": "2024-12-12",
"completion_date": "2028-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Faeth Therapeutics",
"sponsor_slug": "faeth-therapeutics",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06699212",
"publication_url": "https://clinicaltrials.gov/study/NCT06699212",
"title": "A Phase 3 Multicenter, Randomized, Open-label Study of ASP-1929 Photoimmunotherapy in Combination With Pembrolizumab Versus Standard of Care in the First-line Treatment of Patients With Locoregional Recurrence of Squamous Cell Carcinoma of the Head and Neck (HNSCC) With No Distant Metastases",
"has_exemption": false,
"start_date": "2024-12-24",
"completion_date": "2028-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Rakuten Medical, Inc.",
"sponsor_slug": "rakuten-medical-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05046106",
"publication_url": "https://clinicaltrials.gov/study/NCT05046106",
"title": "A Randomized, Double-Blind, Placebo-Controlled, Dose-Response Efficacy and Safety Study of MLC1501 in Patients With Stroke",
"has_exemption": false,
"start_date": "2025-01-31",
"completion_date": "2028-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Moleac Pte Ltd.",
"sponsor_slug": "moleac-pte-ltd",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06931561",
"publication_url": "https://clinicaltrials.gov/study/NCT06931561",
"title": "Occupational Cancer Screening in Firefighters: A Pilot Study Within the Inova Health System",
"has_exemption": false,
"start_date": "2025-02-11",
"completion_date": "2028-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Inova Health Care Services",
"sponsor_slug": "inova-health-care-services",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06649058",
"publication_url": "https://clinicaltrials.gov/study/NCT06649058",
"title": "EXCLAIM: Exploring Combined Local and Systemic Approaches In Brain Metastasis: a Multi-cohort Randomized Phase II Study Evaluating Initial Response to Systemic Therapy and Subsequent Integration of Stereotactic Radiosurgery in Patients With Low-risk Brain Metastases and Central Nervous System-active Systemic Therapy Options",
"has_exemption": false,
"start_date": "2025-02-14",
"completion_date": "2028-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "M.D. Anderson Cancer Center",
"sponsor_slug": "md-anderson-cancer-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06847321",
"publication_url": "https://clinicaltrials.gov/study/NCT06847321",
"title": "A Randomized, Double-Blind, Placebo-Controlled Study of LHP588 in Subjects With P. Gingivalis-Positive Alzheimer's Disease",
"has_exemption": false,
"start_date": "2025-02-17",
"completion_date": "2028-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Lighthouse Pharmaceuticals, Inc.",
"sponsor_slug": "lighthouse-pharmaceuticals-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06406777",
"publication_url": "https://clinicaltrials.gov/study/NCT06406777",
"title": "Validation of MRI, CT and Pulmonary Function Tests for Early Detection of Chronic Lung Allograft Dysfunction",
"has_exemption": false,
"start_date": "2025-03-20",
"completion_date": "2028-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Sean Fain",
"sponsor_slug": "sean-fain",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05940493",
"publication_url": "https://clinicaltrials.gov/study/NCT05940493",
"title": "A Phase 2 Multicenter, Double-blind, Randomized-controlled Study of Abemaciclib (CDK4 and 6 Inhibitor) in Newly Diagnosed RB-proficient Grade 3 Meningioma Participants",
"has_exemption": false,
"start_date": "2025-03-24",
"completion_date": "2028-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Nader Sanai",
"sponsor_slug": "nader-sanai",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06880744",
"publication_url": "https://clinicaltrials.gov/study/NCT06880744",
"title": "Phase 3b, Multicenter, Randomized, Open-Label Study of Risankizumab Compared to Vedolizumab for the Treatment of Adult Subjects With Moderate to Severe Ulcerative Colitis Who Are Naïve to Targeted Therapies",
"has_exemption": false,
"start_date": "2025-06-17",
"completion_date": "2028-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "AbbVie",
"sponsor_slug": "abbvie",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07020221",
"publication_url": "https://clinicaltrials.gov/study/NCT07020221",
"title": "A Phase 1/2a, Open-label Study of VS-7375, a KRAS G12D (ON/OFF) Inhibitor, as Monotherapy and in Combination, in Patients With Advanced KRAS G12D-Mutated Solid Tumors",
"has_exemption": false,
"start_date": "2025-06-24",
"completion_date": "2028-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Verastem, Inc.",
"sponsor_slug": "verastem-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06649695",
"publication_url": "https://clinicaltrials.gov/study/NCT06649695",
"title": "A Phase II Trial of Teclistamab in Participants With Previously Treated Immunoglobulin Light-chain (AL) Amyloidosis",
"has_exemption": false,
"start_date": "2025-07-02",
"completion_date": "2028-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "European Myeloma Network B.V.",
"sponsor_slug": "european-myeloma-network-bv",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07047716",
"publication_url": "https://clinicaltrials.gov/study/NCT07047716",
"title": "A Phase 3, Single-Arm Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Once-Yearly Intramuscular Lenacapavir for HIV Pre-exposure Prophylaxis (PrEP) in People With an Indication for PrEP",
"has_exemption": false,
"start_date": "2025-07-22",
"completion_date": "2028-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Gilead Sciences",
"sponsor_slug": "gilead-sciences",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07112183",
"publication_url": "https://clinicaltrials.gov/study/NCT07112183",
"title": "An Open Label Study to Assess Efficacy of Oral Treprostinil Titrated to 3.0mg Three Times Daily or Highest Tolerable Dose in 30 Patients With Symptomatic Primary or Secondary Raynaud's Phenomenon Resistant to Standard Vasodilatory Therapy",
"has_exemption": false,
"start_date": "2025-08-01",
"completion_date": "2028-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Brigham and Women's Hospital",
"sponsor_slug": "brigham-and-womens-hospital",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07179601",
"publication_url": "https://clinicaltrials.gov/study/NCT07179601",
"title": "Hemorrhoidal Artery Embolization: Longitudinal Impact On Symptoms (HELIOS)",
"has_exemption": false,
"start_date": "2025-08-05",
"completion_date": "2028-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "University of California, Los Angeles",
"sponsor_slug": "university-of-california-los-angeles",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06799494",
"publication_url": "https://clinicaltrials.gov/study/NCT06799494",
"title": "Comparing the Antibody and B Cell Responses Induced by 1- or 2-dose 9-valent HPV (9vHPV) Vaccination in Healthy Adults",
"has_exemption": false,
"start_date": "2025-08-06",
"completion_date": "2028-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Emory University",
"sponsor_slug": "emory-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07128589",
"publication_url": "https://clinicaltrials.gov/study/NCT07128589",
"title": "Clinical Evaluation of 3M(TM) Filtek(TM) Supreme Flowable Composites for Class IV and Veneers",
"has_exemption": false,
"start_date": "2025-08-07",
"completion_date": "2028-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "New York University",
"sponsor_slug": "new-york-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06833320",
"publication_url": "https://clinicaltrials.gov/study/NCT06833320",
"title": "A Double-blind, Prospective, Randomized Trial of Propranolol for the Treatment of Postoperative Chylothorax After Open Cardiac Surgery",
"has_exemption": false,
"start_date": "2025-09-09",
"completion_date": "2028-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "June Wu",
"sponsor_slug": "june-wu",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07197827",
"publication_url": "https://clinicaltrials.gov/study/NCT07197827",
"title": "A Phase 1/2, Multicenter, Open-Label, First-in-Human Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Efficacy of YL242 Monotherapy and Combinations in Advanced Solid Tumors.",
"has_exemption": false,
"start_date": "2025-09-22",
"completion_date": "2028-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "MediLink Therapeutics (Suzhou) Co., Ltd.",
"sponsor_slug": "medilink-therapeutics-suzhou-co-ltd",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07043608",
"publication_url": "https://clinicaltrials.gov/study/NCT07043608",
"title": "A Phase II Study of Zanzalintinib for Metastatic Clear Cell Renal Cell Carcinoma With Bone Metastases in Patients Previously Treated With Immune Checkpoint Inhibitors",
"has_exemption": false,
"start_date": "2025-09-30",
"completion_date": "2028-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Kelly Fitzgerald, MD",
"sponsor_slug": "kelly-fitzgerald-md",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07101809",
"publication_url": "https://clinicaltrials.gov/study/NCT07101809",
"title": "Evaluating the Safety and Effectiveness of Steerable Ureteroscopic Renal Evacuation (SURE) With the CVAC® System Compared to Standard Ureteroscopy With no Suction for the Treatment of Renal Stones: a Prospective, Randomized Trial",
"has_exemption": false,
"start_date": "2025-09-30",
"completion_date": "2028-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Calyxo, Inc.",
"sponsor_slug": "calyxo-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07122713",
"publication_url": "https://clinicaltrials.gov/study/NCT07122713",
"title": "Multi-institutional Prospective Pilot Study of Definitive Breast Radiation Therapy for Invasive Breast Cancer Patients Not Undergoing Definitive Surgery",
"has_exemption": false,
"start_date": "2025-09-30",
"completion_date": "2028-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Alexander Stessin",
"sponsor_slug": "alexander-stessin",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07132190",
"publication_url": "https://clinicaltrials.gov/study/NCT07132190",
"title": "A Double-Blind Phase II Randomized Study of Adaptively Delivered LINAC-Based Stereotactic Radiation for Volatile Brain Metastases With Same-Day Planning and Margin Reduction",
"has_exemption": false,
"start_date": "2025-09-30",
"completion_date": "2028-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Ayal A. Aizer, MD",
"sponsor_slug": "ayal-a-aizer-md",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07201298",
"publication_url": "https://clinicaltrials.gov/study/NCT07201298",
"title": "A Prospective Contralateral Comparison of Ray-Tracing Guided LASIK (WaveLight® Plus LASIK) vs. Small Incision Lenticule Extraction (SMILE® Pro) Using VisuMax® 800, or Wavefront Optimized LASIK or Topography Guided LASIK (Contoura LASIK): A Three-Phase Visual Outcomes Study.",
"has_exemption": false,
"start_date": "2025-09-30",
"completion_date": "2028-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Hoopes Vision",
"sponsor_slug": "hoopes-vision",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07183644",
"publication_url": "https://clinicaltrials.gov/study/NCT07183644",
"title": "Maximizing Laser Therapy Success for Port-Wine Birthmarks in Pediatric Patients",
"has_exemption": false,
"start_date": "2025-09-30",
"completion_date": "2028-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Texas Southwestern Medical Center",
"sponsor_slug": "university-of-texas-southwestern-medical-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06745908",
"publication_url": "https://clinicaltrials.gov/study/NCT06745908",
"title": "ResQ201A: Randomized, Open-Label, Phase 3 Clinical Trial of N-803 Plus Tislelizumab and Docetaxel Versus Docetaxel Monotherapy in Participants With Advanced or Metastatic Non-Small Cell Lung Cancer Who Have Acquired Resistance to Immune Checkpoint Inhibitor Therapy",
"has_exemption": false,
"start_date": "2025-10-01",
"completion_date": "2028-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "ImmunityBio, Inc.",
"sponsor_slug": "immunitybio-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07070219",
"publication_url": "https://clinicaltrials.gov/study/NCT07070219",
"title": "A Single-Arm, Open-Label, Multi-Center, Phase 1b/ 2 Study to Evaluate the Safety, Efficacy, and Cellular Pharmacokinetic Profile of CTD402 in Participants With Relapsed/Refractory T-cell Acute Lymphoblastic Leukemia (T-ALL) and Lymphoblastic Lymphoma (T-LBL) (TENACITY-01)",
"has_exemption": false,
"start_date": "2025-10-07",
"completion_date": "2028-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "BIOHENG THERAPEUTICS US LLC",
"sponsor_slug": "bioheng-therapeutics-us-llc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07186660",
"publication_url": "https://clinicaltrials.gov/study/NCT07186660",
"title": "Evaluation of a Novel Insulin Sensitizer on Glycemic Control, Insulin Usage, and Cardiovascular Biomarkers in People With Type 1 Diabetes Who Use Closed-loop Automated Insulin Delivery",
"has_exemption": false,
"start_date": "2025-10-15",
"completion_date": "2028-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Virginia",
"sponsor_slug": "university-of-virginia",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07224542",
"publication_url": "https://clinicaltrials.gov/study/NCT07224542",
"title": "Smart Soft Contact Lenses for Continuous 24-hour Monitoring of Intraocular Pressure in Glaucoma Care",
"has_exemption": false,
"start_date": "2025-10-19",
"completion_date": "2028-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Indiana University",
"sponsor_slug": "indiana-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07256392",
"publication_url": "https://clinicaltrials.gov/study/NCT07256392",
"title": "A Phase 3b Long-term Efficacy and Safety Extension Study of Barzolvolimab in Participants With Chronic Spontaneous Urticaria Who Have Completed CDX0159-12 or CDX0159-13",
"has_exemption": false,
"start_date": "2025-11-25",
"completion_date": "2028-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Celldex Therapeutics",
"sponsor_slug": "celldex-therapeutics",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07215325",
"publication_url": "https://clinicaltrials.gov/study/NCT07215325",
"title": "The Effects of Doxycycline on Inflammation and the Microbiome: 'Flipping the Script' on STI PEP",
"has_exemption": false,
"start_date": "2025-11-30",
"completion_date": "2028-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Emory University",
"sponsor_slug": "emory-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07182227",
"publication_url": "https://clinicaltrials.gov/study/NCT07182227",
"title": "A Phase 1/2 Multicenter, Open Label, Two-part Study (Single Ascending Dose [Part 1], and Dose Expansion [Part 2]) to Evaluate Safety, Tolerability and Efficacy of PS-002, a Gene Therapy for the Treatment of Adult Participants With Primary IgA Nephropathy",
"has_exemption": false,
"start_date": "2025-11-30",
"completion_date": "2028-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Purespring Therapeutics Limited",
"sponsor_slug": "purespring-therapeutics-limited",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07179952",
"publication_url": "https://clinicaltrials.gov/study/NCT07179952",
"title": "A Study to Evaluate Efficacy and Safety of Slow Release DHEA",
"has_exemption": false,
"start_date": "2025-12-30",
"completion_date": "2028-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Indiana University",
"sponsor_slug": "indiana-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07049055",
"publication_url": "https://clinicaltrials.gov/study/NCT07049055",
"title": "A Phase I/IIa Randomized Clinical Trial to Evaluate the Efficacy of EGFR-targeted, PNU-159682-packaged Nanocells & Glycolipid-Packaged Nanocells in Combination With Gemcitabine & Nab-paclitaxel in Metastatic Pancreatic Ductal Adenocarcinoma",
"has_exemption": false,
"start_date": "2025-12-31",
"completion_date": "2028-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Engeneic Pty Limited",
"sponsor_slug": "engeneic-pty-limited",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07226791",
"publication_url": "https://clinicaltrials.gov/study/NCT07226791",
"title": "A Phase 2 Double-Blind, Placebo-Controlled, Adaptive, Dose-Escalation Study to Evaluate the Safety and Efficacy of AGN-151607-DP (USAN: gemibotulinumtoxinA) for the Achievement of Primary Fascial Closure Without the Use of Component Separation Technique, in Subjects Undergoing Open Abdominal Ventral Hernia Repair",
"has_exemption": false,
"start_date": "2026-02-28",
"completion_date": "2028-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "AbbVie",
"sponsor_slug": "abbvie",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05249556",
"publication_url": "https://clinicaltrials.gov/study/NCT05249556",
"title": "Double-blind, Randomized, Placebo-controlled Trial of Adjunctive Ganaxolone in the Treatment of Seizures Associated With Genetically Confirmed Cyclin-dependent Kinase-like 5 (CDKL5) Deficiency Disorder (CDD) in Pediatric Patients From 6 Months to Less Than 2 Years of Age.",
"has_exemption": false,
"start_date": "2026-06-30",
"completion_date": "2028-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Immedica Pharma AB",
"sponsor_slug": "immedica-pharma-ab",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07006805",
"publication_url": "https://clinicaltrials.gov/study/NCT07006805",
"title": "RESET-MS: A Phase 1/2, Open-Label Study to Evaluate the Safety and Efficacy of Autologous CD19-specific Chimeric Antigen Receptor T Cells (CABA-201) in Participants With Multiple Sclerosis",
"has_exemption": false,
"start_date": "2026-06-30",
"completion_date": "2028-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Cabaletta Bio",
"sponsor_slug": "cabaletta-bio",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06979076",
"publication_url": "https://clinicaltrials.gov/study/NCT06979076",
"title": "A Phase Ib Study of the Selective PKC-β Inhibitor MS-553 in Patients With Refractory or Relapsed Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma",
"has_exemption": false,
"start_date": "2026-07-31",
"completion_date": "2028-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "MingSight Pharmaceuticals, Inc.",
"sponsor_slug": "mingsight-pharmaceuticals-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05864313",
"publication_url": "https://clinicaltrials.gov/study/NCT05864313",
"title": "Gaze and Gait Training With Neuromodulation",
"has_exemption": false,
"start_date": "2026-09-30",
"completion_date": "2028-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Florida",
"sponsor_slug": "university-of-florida",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04301843",
"publication_url": "https://clinicaltrials.gov/study/NCT04301843",
"title": "Phase II Trial of Eflornithine (DFMO) and Etoposide for Relapsed/Refractory Neuroblastoma",
"has_exemption": false,
"start_date": "2020-09-25",
"completion_date": "2028-10-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Giselle Sholler",
"sponsor_slug": "giselle-sholler",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04269902",
"publication_url": "https://clinicaltrials.gov/study/NCT04269902",
"title": "Randomized, Phase III Study of Early Intervention With Venetoclax and Obinutuzumab Versus Delayed Therapy With Venetoclax and Obinutuzumab in Newly Diagnosed Asymptomatic High-Risk Patients With Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL): EVOLVE CLL/SLL Study",
"has_exemption": false,
"start_date": "2021-03-02",
"completion_date": "2028-10-01",
"has_results": false,
"results_due": false,
"sponsor_name": "National Cancer Institute (NCI)",
"sponsor_slug": "national-cancer-institute-nci",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05058651",
"publication_url": "https://clinicaltrials.gov/study/NCT05058651",
"title": "Randomized Phase II/III Trial of First Line Platinum/Etoposide With or Without Atezolizumab (NSC#783608) in Patients With Poorly Differentiated Extrapulmonary Small Cell Neuroendocrine Carcinomas (NEC)",
"has_exemption": false,
"start_date": "2022-06-28",
"completion_date": "2028-10-01",
"has_results": false,
"results_due": false,
"sponsor_name": "National Cancer Institute (NCI)",
"sponsor_slug": "national-cancer-institute-nci",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05518188",
"publication_url": "https://clinicaltrials.gov/study/NCT05518188",
"title": "A Phase 1/2 Open-label Intrathecal Administration of MELPIDA to Determine Its Safety and Efficacy for Patients with Spastic Paraplegia Type 50 (SPG50) Caused by Mutation in the AP4M1 Gene.",
"has_exemption": false,
"start_date": "2023-02-15",
"completion_date": "2028-10-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Elpida Therapeutics SPC",
"sponsor_slug": "elpida-therapeutics-spc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05554328",
"publication_url": "https://clinicaltrials.gov/study/NCT05554328",
"title": "A Randomized Trial of Selumetinib and Olaparib or Selumetinib Alone in Patients With Recurrent or Persistent RAS Pathway Mutant Ovarian and Endometrial Cancers: A ComboMATCH Treatment Trial",
"has_exemption": false,
"start_date": "2023-04-25",
"completion_date": "2028-10-01",
"has_results": false,
"results_due": false,
"sponsor_name": "National Cancer Institute (NCI)",
"sponsor_slug": "national-cancer-institute-nci",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06349434",
"publication_url": "https://clinicaltrials.gov/study/NCT06349434",
"title": "The Utilization Effects of Powered Wearable Orthotics in Improving Upper Extremity Function and ADL in Persons With SCI",
"has_exemption": false,
"start_date": "2023-10-15",
"completion_date": "2028-10-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Kessler Foundation",
"sponsor_slug": "kessler-foundation",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06099444",
"publication_url": "https://clinicaltrials.gov/study/NCT06099444",
"title": "The Effects of Muscle Synergy-Based Biofeedback During Gait Rehabilitation for Individuals With Chronic Stroke",
"has_exemption": false,
"start_date": "2024-03-19",
"completion_date": "2028-10-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Shirley Ryan AbilityLab",
"sponsor_slug": "shirley-ryan-abilitylab",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06516978",
"publication_url": "https://clinicaltrials.gov/study/NCT06516978",
"title": "A Prospective, Open-Label, Multicenter, Randomized Controlled Study Comparing the Efficacy and Safety of Polatuzumab Vedotin, Rituximab, Cyclophosphamide, Doxorubicin, and Prednisone Combined With Orelabrutinib/Chidamide/Venetoclax/Lenalidomide/PD1 (Pola-RCHP-X) Versus RCHOP-X and Pola-RCHP in Previously Untreated Patients With Diffuse Large B-Cell Lymphoma",
"has_exemption": false,
"start_date": "2024-10-01",
"completion_date": "2028-10-01",
"has_results": false,
"results_due": false,
"sponsor_name": "The First Affiliated Hospital with Nanjing Medical University",
"sponsor_slug": "the-first-affiliated-hospital-with-nanjing-medical-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06635629",
"publication_url": "https://clinicaltrials.gov/study/NCT06635629",
"title": "Phase II Prospective Evaluation of Desmopressin Stimulation Test Performance in ACTH-dependent Cushing s Syndrome",
"has_exemption": false,
"start_date": "2024-12-12",
"completion_date": "2028-10-01",
"has_results": false,
"results_due": false,
"sponsor_name": "National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)",
"sponsor_slug": "national-institute-of-diabetes-and-digestive-and-kidney-diseases-niddk",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06644183",
"publication_url": "https://clinicaltrials.gov/study/NCT06644183",
"title": "A Phase 1/2, Open Label, Study of Roginolisib (IOA-244), an Orally Bioavailable, Selective PI3Kδ Inhibitor in Patients With Refractory/Relapsed Chronic Lymphocytic Leukemia (CLL) in Combination With Venetoclax and Rituximab",
"has_exemption": false,
"start_date": "2025-03-19",
"completion_date": "2028-10-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Jennifer R. Brown, MD, PhD",
"sponsor_slug": "jennifer-r-brown-md-phd",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06480760",
"publication_url": "https://clinicaltrials.gov/study/NCT06480760",
"title": "Effects of Carnosine In Patients With Peripheral Arterial Disease Patients; Randomized Intervention Trial (CIPHER)",
"has_exemption": false,
"start_date": "2025-05-20",
"completion_date": "2028-10-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Shahid Baba",
"sponsor_slug": "shahid-baba",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07209449",
"publication_url": "https://clinicaltrials.gov/study/NCT07209449",
"title": "Phase II Study of ELacestrant in Combination With Abemaciclib or Elacestrant Alone In p53 Wild Type, Estrogen Receptor-positive Advanced or recurrenT Endometrial Cancer (ELITE)",
"has_exemption": false,
"start_date": "2025-10-01",
"completion_date": "2028-10-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Memorial Sloan Kettering Cancer Center",
"sponsor_slug": "memorial-sloan-kettering-cancer-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06986174",
"publication_url": "https://clinicaltrials.gov/study/NCT06986174",
"title": "A Phase 2 Study to Evaluate the Safety and Efficacy of Pacritinib in Relapsed or Refractory Waldenström Macroglobulinemia",
"has_exemption": false,
"start_date": "2025-11-30",
"completion_date": "2028-10-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Shayna Sarosiek, MD",
"sponsor_slug": "shayna-sarosiek-md",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06412120",
"publication_url": "https://clinicaltrials.gov/study/NCT06412120",
"title": "Single-Arm, Prospective, Multicenter Study Evaluating Safety, Tolerability, and Metabolism of Niraparib as Maintenance Following Front-Line Treatment for Ovarian Cancer in Women of African Ancestry",
"has_exemption": false,
"start_date": "2025-12-01",
"completion_date": "2028-10-01",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Miami",
"sponsor_slug": "university-of-miami",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07217938",
"publication_url": "https://clinicaltrials.gov/study/NCT07217938",
"title": "TRADstat: Novel Treatment of Radiation Associated Dysphagia With Statins",
"has_exemption": false,
"start_date": "2025-12-01",
"completion_date": "2028-10-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Peter MacCallum Cancer Centre, Australia",
"sponsor_slug": "peter-maccallum-cancer-centre-australia",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07013591",
"publication_url": "https://clinicaltrials.gov/study/NCT07013591",
"title": "Randomized Clinical Trial of β Nicotinamide Mononucleotide in Patients Undergoing CABG Surgery",
"has_exemption": false,
"start_date": "2025-12-15",
"completion_date": "2028-10-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Brigham and Women's Hospital",
"sponsor_slug": "brigham-and-womens-hospital",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06408246",
"publication_url": "https://clinicaltrials.gov/study/NCT06408246",
"title": "ACE-D: Accelerating Cognition-guided Signatures to Enhance Translation in Depression: Clinical Trial",
"has_exemption": false,
"start_date": "2026-02-01",
"completion_date": "2028-10-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Stanford University",
"sponsor_slug": "stanford-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06833008",
"publication_url": "https://clinicaltrials.gov/study/NCT06833008",
"title": "An Open-label, Phase I/II First-in-human, Dose Escalation and Confirmation Study to Evaluate the Safety, Tolerability, Pharmacokinetic, Pharmacodynamic and Anti-tumour Activity of IPN01195 as Single Agent in Adult Participants With Advanced Solid Tumours",
"has_exemption": false,
"start_date": "2025-03-14",
"completion_date": "2028-10-03",
"has_results": false,
"results_due": false,
"sponsor_name": "Ipsen",
"sponsor_slug": "ipsen",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06202274",
"publication_url": "https://clinicaltrials.gov/study/NCT06202274",
"title": "Clinical Study to Evaluate the Safety and Efficacy of Candela Technology",
"has_exemption": false,
"start_date": "2023-10-04",
"completion_date": "2028-10-04",
"has_results": false,
"results_due": false,
"sponsor_name": "Candela Corporation",
"sponsor_slug": "candela-corporation",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06003387",
"publication_url": "https://clinicaltrials.gov/study/NCT06003387",
"title": "Phase 3b, Open-label, Multicenter, Single-dose Study Investigating Efficacy and Safety of CSL222 (Etranacogene Dezaparvovec) Gene Therapy Administered to Adult Subjects With Severe or Moderately Severe Hemophilia B With Detectable Pretreatment AAV5 Neutralizing Antibodies",
"has_exemption": false,
"start_date": "2024-01-30",
"completion_date": "2028-10-04",
"has_results": false,
"results_due": false,
"sponsor_name": "CSL Behring",
"sponsor_slug": "csl-behring",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05835310",
"publication_url": "https://clinicaltrials.gov/study/NCT05835310",
"title": "A Phase III, Randomized, Double-blind, Parallel-group, Placebo Controlled Study to Evaluate the Pharmacokinetics, Pharmacodynamics, Efficacy, and Safety of IV Anifrolumab in Pediatric Participants 5 to < 18 Years of Age With Moderate to Severe Active Systemic Lupus Erythematosus (SLE) While on Background Standard of Care Therapy",
"has_exemption": false,
"start_date": "2024-03-14",
"completion_date": "2028-10-05",
"has_results": false,
"results_due": false,
"sponsor_name": "AstraZeneca",
"sponsor_slug": "astrazeneca",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT00801489",
"publication_url": "https://clinicaltrials.gov/study/NCT00801489",
"title": "A Phase 2 Study of Fludarabine, Cytarabine, Filgrastim-sndz,Gemtuzumab Ozogamicin and Idarubicin in Newly Diagnosed Core Binding Factor Associated Acute Myelogenous Leukemia",
"has_exemption": false,
"start_date": "2007-04-04",
"completion_date": "2028-10-11",
"has_results": false,
"results_due": false,
"sponsor_name": "M.D. Anderson Cancer Center",
"sponsor_slug": "md-anderson-cancer-center",
"status": "ongoing",
"is_pact": true,
"days_late": null
},
{
"registry_id": "NCT01878617",
"publication_url": "https://clinicaltrials.gov/study/NCT01878617",
"title": "A Clinical and Molecular Risk-Directed Therapy for Newly Diagnosed Medulloblastoma",
"has_exemption": false,
"start_date": "2013-06-23",
"completion_date": "2028-10-13",
"has_results": false,
"results_due": false,
"sponsor_name": "St. Jude Children's Research Hospital",
"sponsor_slug": "st-jude-childrens-research-hospital",
"status": "ongoing",
"is_pact": true,
"days_late": null
},
{
"registry_id": "NCT06492291",
"publication_url": "https://clinicaltrials.gov/study/NCT06492291",
"title": "A Phase 3, Open-label Extension Study to Evaluate the Safety and Efficacy of MK-0616 in Adults With Hypercholesterolemia",
"has_exemption": false,
"start_date": "2024-08-05",
"completion_date": "2028-10-13",
"has_results": false,
"results_due": false,
"sponsor_name": "Merck Sharp & Dohme LLC",
"sponsor_slug": "merck-sharp-dohme-llc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06996782",
"publication_url": "https://clinicaltrials.gov/study/NCT06996782",
"title": "A Phase Ib/II Open-Label, Multicentre Platform Study Evaluating Novel Combinations in Participants With Advanced or Metastatic Non-Small Cell Lung Cancer",
"has_exemption": false,
"start_date": "2025-10-13",
"completion_date": "2028-10-13",
"has_results": false,
"results_due": false,
"sponsor_name": "AstraZeneca",
"sponsor_slug": "astrazeneca",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07223047",
"publication_url": "https://clinicaltrials.gov/study/NCT07223047",
"title": "A Phase 1/2a, Open-Label, Multicenter Study to Assess the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Preliminary Efficacy of BMS-986523 As Monotherapy and in Combination With Anti-Cancer Agents in Participants With Advanced Solid Malignancies",
"has_exemption": false,
"start_date": "2025-11-26",
"completion_date": "2028-10-13",
"has_results": false,
"results_due": false,
"sponsor_name": "Bristol-Myers Squibb",
"sponsor_slug": "bristol-myers-squibb",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06072781",
"publication_url": "https://clinicaltrials.gov/study/NCT06072781",
"title": "A Phase 3, Randomized, Open-Label Study of Combination Therapy With Avutometinib Plus Defactinib Versus Investigator's Choice of Treatment in Patients With Recurrent Low-Grade Serous Ovarian Cancer (LGSOC) (RAMP 301)",
"has_exemption": false,
"start_date": "2024-03-18",
"completion_date": "2028-10-15",
"has_results": false,
"results_due": false,
"sponsor_name": "Verastem, Inc.",
"sponsor_slug": "verastem-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06815003",
"publication_url": "https://clinicaltrials.gov/study/NCT06815003",
"title": "Phase-2 Study of Vedolizumab Plus Post-Transplant Cyclophosphamide and Short Course Tacrolimus for Graft-versus-Host Disease Prevention After Reduced Intensity Conditioning Peripheral Blood Stem Cell Allogeneic Hematopoietic Cell Transplantation",
"has_exemption": false,
"start_date": "2025-04-18",
"completion_date": "2028-10-15",
"has_results": false,
"results_due": false,
"sponsor_name": "City of Hope Medical Center",
"sponsor_slug": "city-of-hope-medical-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06796998",
"publication_url": "https://clinicaltrials.gov/study/NCT06796998",
"title": "Phase 2 Trial of Epcoritamab in Patients With Newly Diagnosed Marginal Zone Lymphoma (MZL)",
"has_exemption": false,
"start_date": "2025-10-13",
"completion_date": "2028-10-15",
"has_results": false,
"results_due": false,
"sponsor_name": "Izidore Lossos, MD",
"sponsor_slug": "izidore-lossos-md",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04067336",
"publication_url": "https://clinicaltrials.gov/study/NCT04067336",
"title": "A Phase 1/2 First in Human Study of the Menin-MLL(KMT2A) Inhibitor KO-539 in Patients With Relapsed or Refractory Acute Myeloid Leukemia",
"has_exemption": false,
"start_date": "2019-09-12",
"completion_date": "2028-10-16",
"has_results": false,
"results_due": false,
"sponsor_name": "Kura Oncology, Inc.",
"sponsor_slug": "kura-oncology-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06572384",
"publication_url": "https://clinicaltrials.gov/study/NCT06572384",
"title": "A Phase 3, Randomized, Double-Blind, Placebo Controlled, Parallel Group Study to Evaluate the Efficacy and Safety of Belimumab Administered Subcutaneously in Adults With Interstitial Lung Disease (ILD) Associated With Connective Tissue Disease (CTD)",
"has_exemption": false,
"start_date": "2024-09-11",
"completion_date": "2028-10-18",
"has_results": false,
"results_due": false,
"sponsor_name": "GlaxoSmithKline",
"sponsor_slug": "glaxosmithkline",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07197944",
"publication_url": "https://clinicaltrials.gov/study/NCT07197944",
"title": "A Phase 3, Double-blind, Randomized, Parallel Group, Placebo-controlled, Multicenter Trial to Confirm the Efficacy and Safety of Glepaglutide 10 mg Twice Weekly, Followed by a Long-term, Open-label Safety Evaluation in Patients With Short Bowel Syndrome-intestinal Failure (SBS-IF)",
"has_exemption": false,
"start_date": "2025-10-23",
"completion_date": "2028-10-23",
"has_results": false,
"results_due": false,
"sponsor_name": "Zealand Pharma",
"sponsor_slug": "zealand-pharma",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06818643",
"publication_url": "https://clinicaltrials.gov/study/NCT06818643",
"title": "A Phase 1/2 Open-label Study to Evaluate the Safety and Efficacy of MK-3120 in Participants With Advanced Solid Tumors",
"has_exemption": false,
"start_date": "2025-03-25",
"completion_date": "2028-10-25",
"has_results": false,
"results_due": false,
"sponsor_name": "Merck Sharp & Dohme LLC",
"sponsor_slug": "merck-sharp-dohme-llc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07109414",
"publication_url": "https://clinicaltrials.gov/study/NCT07109414",
"title": "Randomized Phase 2/3 Trial of NP-G2-044 (Prilukae) Combined With PLD for Treatment of Platinum-Resistant Ovarian Cancer (ULTIMUS-1)",
"has_exemption": false,
"start_date": "2025-11-30",
"completion_date": "2028-10-25",
"has_results": false,
"results_due": false,
"sponsor_name": "Novita Pharmaceuticals, Inc.",
"sponsor_slug": "novita-pharmaceuticals-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT02407028",
"publication_url": "https://clinicaltrials.gov/study/NCT02407028",
"title": "Hyperbaric Oxygen Brain Injury Treatment (HOBIT) Trial",
"has_exemption": false,
"start_date": "2018-06-25",
"completion_date": "2028-10-26",
"has_results": false,
"results_due": false,
"sponsor_name": "Gaylan Rockswold",
"sponsor_slug": "gaylan-rockswold",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05755386",
"publication_url": "https://clinicaltrials.gov/study/NCT05755386",
"title": "A Multicenter, Randomized, Double-blind, Parallel Group, Placebo-controlled Study to Evaluate the Efficacy and Safety of Iptacopan (LNP023) in Idiopathic Immune-complex-mediated Membranoproliferative Glomerulonephritis (IC-MPGN)",
"has_exemption": false,
"start_date": "2023-10-02",
"completion_date": "2028-10-27",
"has_results": false,
"results_due": false,
"sponsor_name": "Novartis Pharmaceuticals",
"sponsor_slug": "novartis-pharmaceuticals",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05451849",
"publication_url": "https://clinicaltrials.gov/study/NCT05451849",
"title": "A Phase 1/2 Single Arm Open-Label Clinical Trial of TC-510 In Patients With Advanced Mesothelin-Expressing Cancer",
"has_exemption": false,
"start_date": "2022-06-21",
"completion_date": "2028-10-30",
"has_results": false,
"results_due": false,
"sponsor_name": "TCR2 Therapeutics",
"sponsor_slug": "tcr2-therapeutics",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06430801",
"publication_url": "https://clinicaltrials.gov/study/NCT06430801",
"title": "A Phase 3, Randomized, Double-Blind, Placebo-Controlled Program to Evaluate the Efficacy and Safety of Tulisokibart in Participants With Moderately to Severely Active Crohn's Disease",
"has_exemption": false,
"start_date": "2024-06-05",
"completion_date": "2028-10-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Merck Sharp & Dohme LLC",
"sponsor_slug": "merck-sharp-dohme-llc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06678659",
"publication_url": "https://clinicaltrials.gov/study/NCT06678659",
"title": "A Phase 1 / 2, Open-Label Study of REC-1245 in Participants With Unresectable, Locally Advanced, or Metastatic Cancer",
"has_exemption": false,
"start_date": "2024-11-21",
"completion_date": "2028-10-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Recursion Pharmaceuticals Inc.",
"sponsor_slug": "recursion-pharmaceuticals-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05952453",
"publication_url": "https://clinicaltrials.gov/study/NCT05952453",
"title": "A Phase II Study in Newly Diagnosed Stage III/IV Epithelial Ovarian Cancer Evaluating Carbo/Taxol/Pembro in Patients Receiving Neoadjuvant Chemotherapy (NACT) Followed by Olaparib/Pembro Maintenance",
"has_exemption": false,
"start_date": "2025-02-17",
"completion_date": "2028-10-30",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Alabama at Birmingham",
"sponsor_slug": "university-of-alabama-at-birmingham",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06873789",
"publication_url": "https://clinicaltrials.gov/study/NCT06873789",
"title": "A Phase 1/2, Open-Label, Multicenter Study of INCB177054 in Participants With Select Advanced or Metastatic Solid Tumors",
"has_exemption": false,
"start_date": "2025-06-30",
"completion_date": "2028-10-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Incyte Corporation",
"sponsor_slug": "incyte-corporation",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06976619",
"publication_url": "https://clinicaltrials.gov/study/NCT06976619",
"title": "The Effect of Glycemic Control and of GLP-1 Receptor Agonism on Islet GLP-1 in People",
"has_exemption": false,
"start_date": "2025-10-03",
"completion_date": "2028-10-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Mayo Clinic",
"sponsor_slug": "mayo-clinic",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07213817",
"publication_url": "https://clinicaltrials.gov/study/NCT07213817",
"title": "An Open-Label, Phase I/II First-in-Human, Dose Escalation, Dose Optimisation and Dose Expansion Study to Evaluate the Safety, Tolerability, Pharmacokinetic, Pharmacodynamic, Immunogenicity and Antitumour Activity of IPN60300 as Single Agent in Adult Participants With Locally Advanced or Metastatic Solid Tumours.",
"has_exemption": false,
"start_date": "2025-11-05",
"completion_date": "2028-10-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Ipsen",
"sponsor_slug": "ipsen",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT03219359",
"publication_url": "https://clinicaltrials.gov/study/NCT03219359",
"title": "Maintenance in Autologous Stem Cell Transplant for Crohn's Disease (MASCT - CD)",
"has_exemption": false,
"start_date": "2018-02-22",
"completion_date": "2028-10-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Aaron Etra",
"sponsor_slug": "aaron-etra",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT03821129",
"publication_url": "https://clinicaltrials.gov/study/NCT03821129",
"title": "GORE® CARDIOFORM Septal Occluder and Antiplatelet Medical Management for Reduction of Recurrent Stroke in Patients With Patent Foramen Ovale (PFO): the REDUCE Post Approval Study",
"has_exemption": false,
"start_date": "2019-07-25",
"completion_date": "2028-10-31",
"has_results": false,
"results_due": false,
"sponsor_name": "W.L.Gore & Associates",
"sponsor_slug": "wlgore-associates",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04230109",
"publication_url": "https://clinicaltrials.gov/study/NCT04230109",
"title": "A Phase 2 Study of Response-guided Neoadjuvant Sacituzumab Govitecan (IMMU-132) in Patients With Localized Triple-Negative Breast Cancer (NeoSTAR)",
"has_exemption": false,
"start_date": "2020-07-14",
"completion_date": "2028-10-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Massachusetts General Hospital",
"sponsor_slug": "massachusetts-general-hospital",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04613596",
"publication_url": "https://clinicaltrials.gov/study/NCT04613596",
"title": "A Phase 2 Trial of Adagrasib Monotherapy and in Combination With Pembrolizumab and a Phase 3 Trial of Adagrasib in Combination With Pembrolizumab Versus Pembrolizumab in Patients With Advanced Non-Small Cell Lung Cancer With KRAS G12C Mutation",
"has_exemption": false,
"start_date": "2020-12-02",
"completion_date": "2028-10-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Mirati Therapeutics Inc.",
"sponsor_slug": "mirati-therapeutics-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04411823",
"publication_url": "https://clinicaltrials.gov/study/NCT04411823",
"title": "Prediction of Post-laparoscopic Sleeve Gastrectomy Gastroesophageal Reflux Disease With an Endolumenal Functional Lumen Imaging Probe (EndoFLIP)",
"has_exemption": false,
"start_date": "2021-02-01",
"completion_date": "2028-10-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Mayo Clinic",
"sponsor_slug": "mayo-clinic",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05153772",
"publication_url": "https://clinicaltrials.gov/study/NCT05153772",
"title": "A Phase 2 Open Label Study to Evaluate the Safety and Effectiveness of 212Pb-DOTAMTATE in Subjects With Somatostatin Receptor Expressing Neuroendocrine Tumors",
"has_exemption": false,
"start_date": "2021-12-21",
"completion_date": "2028-10-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Orano Med LLC",
"sponsor_slug": "orano-med-llc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06342960",
"publication_url": "https://clinicaltrials.gov/study/NCT06342960",
"title": "KYSA-3: A Phase 1/2, Open-Label, Multicenter Study of KYV-101, an Autologous Fully-Human Anti-CD19 Chimeric Antigen Receptor T-Cell (CD19 CAR T) Therapy, in Subjects With Refractory Lupus Nephritis",
"has_exemption": false,
"start_date": "2022-12-01",
"completion_date": "2028-10-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Kyverna Therapeutics",
"sponsor_slug": "kyverna-therapeutics",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05259904",
"publication_url": "https://clinicaltrials.gov/study/NCT05259904",
"title": "Study to Improve dEployment Related Asthma by Using L-citrulline Supplementation (SEALS)",
"has_exemption": false,
"start_date": "2023-03-08",
"completion_date": "2028-10-31",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Colorado, Denver",
"sponsor_slug": "university-of-colorado-denver",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05532943",
"publication_url": "https://clinicaltrials.gov/study/NCT05532943",
"title": "A Seamless Phase I/IIa Clinical Study to Evaluate the Safety and Efficacy of Allogeneic Umbilical Cord Mesenchymal Stem Cells in Patients With Multiple Sclerosis",
"has_exemption": false,
"start_date": "2023-09-08",
"completion_date": "2028-10-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Ever Supreme Bio Technology Co., Ltd.",
"sponsor_slug": "ever-supreme-bio-technology-co-ltd",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05977998",
"publication_url": "https://clinicaltrials.gov/study/NCT05977998",
"title": "A Phase II Study of Perioperative Paclitaxel in Patients With Gastric Adenocarcinoma and Carcinomatosis or Positive Cytology",
"has_exemption": false,
"start_date": "2023-09-08",
"completion_date": "2028-10-31",
"has_results": false,
"results_due": false,
"sponsor_name": "M.D. Anderson Cancer Center",
"sponsor_slug": "md-anderson-cancer-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05821959",
"publication_url": "https://clinicaltrials.gov/study/NCT05821959",
"title": "A Trial of AAVAnc80-hOTOF Gene Therapy in Individuals With Sensorineural Hearing Loss Due to Otoferlin Gene Mutations",
"has_exemption": false,
"start_date": "2023-09-15",
"completion_date": "2028-10-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Akouos, Inc.",
"sponsor_slug": "akouos-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06076304",
"publication_url": "https://clinicaltrials.gov/study/NCT06076304",
"title": "Nasal Steroids, Irrigation, Oral Antibiotics, and Subgroup Targeting for Effective Management of Sinusitis",
"has_exemption": false,
"start_date": "2023-11-21",
"completion_date": "2028-10-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Daniel Merenstein",
"sponsor_slug": "daniel-merenstein",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06140537",
"publication_url": "https://clinicaltrials.gov/study/NCT06140537",
"title": "Efficacy and Mechanisms of Dapagliflozin in Promoting Kidney Function and Cardiovascular Health in Kidney Transplant Recipients",
"has_exemption": false,
"start_date": "2024-02-01",
"completion_date": "2028-10-31",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Colorado, Denver",
"sponsor_slug": "university-of-colorado-denver",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05916235",
"publication_url": "https://clinicaltrials.gov/study/NCT05916235",
"title": "Photobiomodulation for Management of Temporomandibular Disorder Pain",
"has_exemption": false,
"start_date": "2024-02-08",
"completion_date": "2028-10-31",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Florida",
"sponsor_slug": "university-of-florida",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06572683",
"publication_url": "https://clinicaltrials.gov/study/NCT06572683",
"title": "Resonant Frequency rTMS: A Novel Approach to Target Circuit Modulation in Major Depressive Disorder",
"has_exemption": false,
"start_date": "2024-02-12",
"completion_date": "2028-10-31",
"has_results": false,
"results_due": false,
"sponsor_name": "University of California, Los Angeles",
"sponsor_slug": "university-of-california-los-angeles",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06044623",
"publication_url": "https://clinicaltrials.gov/study/NCT06044623",
"title": "Implementing Geriatric Assessment for Dose Optimization of CDK 4/6-inhibitors in Older Breast Cancer Patients - a Pragmatic Randomized-controlled Trial (IMPORTANT Trial)",
"has_exemption": false,
"start_date": "2024-04-01",
"completion_date": "2028-10-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Region Örebro County",
"sponsor_slug": "region-orebro-county",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06590857",
"publication_url": "https://clinicaltrials.gov/study/NCT06590857",
"title": "Phase 1b/2 Open-label Trial of 225Ac-DOTATATE (RYZ101) in Subjects With Estrogen Receptor-positive (ER+), Human Epidermal Growth Factor Receptor 2 (HER2)-Negative, Locally Advanced and Unresectable or Metastatic Breast Cancer Expressing Somatostatin Receptors (SSTRs) and Progressed After Antibody-drug Conjugates and/or Chemotherapy (TRACY-1).",
"has_exemption": false,
"start_date": "2024-07-19",
"completion_date": "2028-10-31",
"has_results": false,
"results_due": false,
"sponsor_name": "RayzeBio, Inc.",
"sponsor_slug": "rayzebio-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06216301",
"publication_url": "https://clinicaltrials.gov/study/NCT06216301",
"title": "LUNAR-2: Pivotal, Randomized, Open-Label Study of Tumor Treating Fields (TTFields, 150 kHz) Concomitant With Pembrolizumab and Platinum-based Chemotherapy for the Treatment of Metastatic Non-Small Cell Lung Cancer",
"has_exemption": false,
"start_date": "2024-07-31",
"completion_date": "2028-10-31",
"has_results": false,
"results_due": false,
"sponsor_name": "NovoCure GmbH",
"sponsor_slug": "novocure-gmbh",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06506422",
"publication_url": "https://clinicaltrials.gov/study/NCT06506422",
"title": "SGLT2 Inhibition as a Therapeutic Strategy to Reverse Arterial Stiffening in Aging",
"has_exemption": false,
"start_date": "2024-08-18",
"completion_date": "2028-10-31",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Missouri-Columbia",
"sponsor_slug": "university-of-missouri-columbia",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06806930",
"publication_url": "https://clinicaltrials.gov/study/NCT06806930",
"title": "Predicting Response to Neoadjuvant Endocrine Therapy (Neo-PREDICT)",
"has_exemption": false,
"start_date": "2024-10-03",
"completion_date": "2028-10-31",
"has_results": false,
"results_due": false,
"sponsor_name": "George Washington University",
"sponsor_slug": "george-washington-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06330493",
"publication_url": "https://clinicaltrials.gov/study/NCT06330493",
"title": "Prospective Multi-Center Randomized Controlled Trial to Evaluate the Safety and Efficacy of AcoArt Litos Paclitaxel Coated Percutaneous Transluminal Angioplasty (PTA) Balloon Versus Non-Coated Standard Balloon Angioplasty for the Treatment of Infrapopliteal Obstructions in Patients With Chronic Limb-Threatening Ischemia",
"has_exemption": false,
"start_date": "2024-10-10",
"completion_date": "2028-10-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Acotec Scientific Co., Ltd",
"sponsor_slug": "acotec-scientific-co-ltd",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05903131",
"publication_url": "https://clinicaltrials.gov/study/NCT05903131",
"title": "UPLifT-Endo: Uterine Preservation Via Lifestyle Transformation A Behavioral Intervention to Promote Primary Prevention and Uterine Preservation in Premenopausal Women With Obesity and Atypical Endometrial Hyperplasia or Grade 1 Endometrial Cancer",
"has_exemption": false,
"start_date": "2024-10-24",
"completion_date": "2028-10-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Washington University School of Medicine",
"sponsor_slug": "washington-university-school-of-medicine",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06733935",
"publication_url": "https://clinicaltrials.gov/study/NCT06733935",
"title": "A Phase 1/2 Study of NKX019, a CD19 Chimeric Antigen Receptor Natural Killer (CAR NK) Cell Therapy, in Subjects With Immune-Mediated Diseases",
"has_exemption": false,
"start_date": "2024-11-04",
"completion_date": "2028-10-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Nkarta, Inc.",
"sponsor_slug": "nkarta-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06614192",
"publication_url": "https://clinicaltrials.gov/study/NCT06614192",
"title": "AndroMETa-CRC-064: An Open Label, Randomized, Controlled, Global Phase 3 Study Comparing Telisotuzumab Adizutecan (ABBV-400) Monotherapy to LONSURF (Trifluridine and Tipiracil) Plus Bevacizumab in Subjects With Refractory Metastatic Colorectal Cancer Expressing c-Met Protein Level Above a Defined Cutoff",
"has_exemption": false,
"start_date": "2024-11-08",
"completion_date": "2028-10-31",
"has_results": false,
"results_due": false,
"sponsor_name": "AbbVie",
"sponsor_slug": "abbvie",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06825689",
"publication_url": "https://clinicaltrials.gov/study/NCT06825689",
"title": "Unidos Contra el VPH: Screening Preference and Uptake of HPV Self-sampling Among Latinxs Along the US-Mexico Border",
"has_exemption": false,
"start_date": "2025-01-28",
"completion_date": "2028-10-31",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Texas at Austin",
"sponsor_slug": "university-of-texas-at-austin",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06942572",
"publication_url": "https://clinicaltrials.gov/study/NCT06942572",
"title": "A Phase 1/2, First-in-Human, Open-label, Assessor-Masked, Randomized, Controlled, Dose Escalation/Expansion Study to Evaluate the Safety, Tolerability and Preliminary Efficacy of a Subretinal Injection of SB-007 in Subjects With Stargardt Disease (STGD1) Caused by Bi-Allelic Autosomal Recessive Mutations in the ATP Binding Cassette Subfamily A Member 4 (ABCA4) Gene",
"has_exemption": false,
"start_date": "2025-02-11",
"completion_date": "2028-10-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Splice Bio",
"sponsor_slug": "splice-bio",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06841055",
"publication_url": "https://clinicaltrials.gov/study/NCT06841055",
"title": "A Phase II, Multisite, Open-label, Single Arm Trial of BNT327 in Combination With Docetaxel in Second-line Stage IV Non-small Cell Lung Cancer (NSCLC) Following Chemoimmunotherapy",
"has_exemption": false,
"start_date": "2025-03-03",
"completion_date": "2028-10-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Biontech SE",
"sponsor_slug": "biontech-se",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06817668",
"publication_url": "https://clinicaltrials.gov/study/NCT06817668",
"title": "Evaluating Tolerability of Elective Pelvic Ultra Hypofractionated Irradiation Treatment (ePUHRT) With High Dose Rate Brachytherapy Boost for Unfavorable and Higher Risk Prostate Cancer",
"has_exemption": false,
"start_date": "2025-03-05",
"completion_date": "2028-10-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Indiana University",
"sponsor_slug": "indiana-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06533865",
"publication_url": "https://clinicaltrials.gov/study/NCT06533865",
"title": "Romosozumab as an Adjunct to Physiologic Estrogen Replacement in Adolescents and Young Adults With Functional Hypothalamic Amenorrhea",
"has_exemption": false,
"start_date": "2025-03-19",
"completion_date": "2028-10-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Massachusetts General Hospital",
"sponsor_slug": "massachusetts-general-hospital",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06727773",
"publication_url": "https://clinicaltrials.gov/study/NCT06727773",
"title": "Memantine and Exercise to Improve Cognitive Function and Modulate Biological Pathways of Cognitive Decline During Chemotherapy in Breast Cancer",
"has_exemption": false,
"start_date": "2025-05-07",
"completion_date": "2028-10-31",
"has_results": false,
"results_due": false,
"sponsor_name": "UNC Lineberger Comprehensive Cancer Center",
"sponsor_slug": "unc-lineberger-comprehensive-cancer-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06960577",
"publication_url": "https://clinicaltrials.gov/study/NCT06960577",
"title": "A Phase IIIb, Open-label, Single-arm, Global Study of Perioperative Durvalumab With Neoadjuvant ddMVAC or Gem/Cis in Patients With Muscle-invasive Bladder Cancer (NIAGARA-2)",
"has_exemption": false,
"start_date": "2025-05-15",
"completion_date": "2028-10-31",
"has_results": false,
"results_due": false,
"sponsor_name": "AstraZeneca",
"sponsor_slug": "astrazeneca",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06680752",
"publication_url": "https://clinicaltrials.gov/study/NCT06680752",
"title": "A Phase 1/2, Open-label, Multicenter Trial to Assess the Safety and Efficacy of ARD103 in Patients With Relapsed or Refractory Acute Myeloid Leukemia or Myelodysplastic Syndrome",
"has_exemption": false,
"start_date": "2025-05-20",
"completion_date": "2028-10-31",
"has_results": false,
"results_due": false,
"sponsor_name": "ARCE Therapeutics, Inc.",
"sponsor_slug": "arce-therapeutics-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06693011",
"publication_url": "https://clinicaltrials.gov/study/NCT06693011",
"title": "Contour Neurovascular System™ ContiNued Access Investigational Device EXempTion (IDE) Trial",
"has_exemption": false,
"start_date": "2025-06-10",
"completion_date": "2028-10-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Cerus Endovascular, Inc.",
"sponsor_slug": "cerus-endovascular-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06980025",
"publication_url": "https://clinicaltrials.gov/study/NCT06980025",
"title": "A Dose Escalation Study of Low Dose Aspirin for the Prevention of Recurrent Preterm Birth",
"has_exemption": false,
"start_date": "2025-06-10",
"completion_date": "2028-10-31",
"has_results": false,
"results_due": false,
"sponsor_name": "The George Washington University Biostatistics Center",
"sponsor_slug": "the-george-washington-university-biostatistics-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06328608",
"publication_url": "https://clinicaltrials.gov/study/NCT06328608",
"title": "Multi-centre, Open-label Trial to Assess the saFety, Pharmacodynamics, Efficacy and Pharmacokinetics of pegunigaLsidase Alfa in Patients From 2 Years to Less Than 18 Years of Age With Confirmed FabrY Disease",
"has_exemption": false,
"start_date": "2025-07-29",
"completion_date": "2028-10-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Chiesi Farmaceutici S.p.A.",
"sponsor_slug": "chiesi-farmaceutici-spa",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07224256",
"publication_url": "https://clinicaltrials.gov/study/NCT07224256",
"title": "VOICE: An Early Feasibility Study of a Precise Robotically Implanted Brain-Computer Interface for Communication Restoration",
"has_exemption": false,
"start_date": "2025-10-03",
"completion_date": "2028-10-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Neuralink Corp",
"sponsor_slug": "neuralink-corp",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06784336",
"publication_url": "https://clinicaltrials.gov/study/NCT06784336",
"title": "Phase II Multi-center Study of Resistant Potato Starch Plus Deferasirox to Improve Outcomes in Patients Undergoing Allogeneic Stem Cell Transplantation",
"has_exemption": false,
"start_date": "2025-10-15",
"completion_date": "2028-10-31",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Michigan Rogel Cancer Center",
"sponsor_slug": "university-of-michigan-rogel-cancer-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07115004",
"publication_url": "https://clinicaltrials.gov/study/NCT07115004",
"title": "A Prospective, Multicenter, Open-label, Phase 3 Clinical Study to Evaluate the Efficacy and Safety of Prophylactic VGA039 in Adolescent and Adult Patients With Von Willebrand Disease (VIVID-6)",
"has_exemption": false,
"start_date": "2025-10-15",
"completion_date": "2028-10-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Vega Therapeutics, Inc",
"sponsor_slug": "vega-therapeutics-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07045194",
"publication_url": "https://clinicaltrials.gov/study/NCT07045194",
"title": "A Prospective, Multi-center, Single-blind, Randomized (1:1), Non-inferiority Study Comparing Clinical Outcomes of the Virtue® Sirolimus AngioInfusion™ Balloon (SAB) to the AGENT™ Paclitaxel Drug-Coated Balloon (DCB) in the Treatment of Coronary Artery In-stent Restenosis (ISR).",
"has_exemption": false,
"start_date": "2025-10-20",
"completion_date": "2028-10-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Orchestra BioMed, Inc",
"sponsor_slug": "orchestra-biomed-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07194850",
"publication_url": "https://clinicaltrials.gov/study/NCT07194850",
"title": "A Multicenter, Randomized, Double-blinded, Parallel-Arm, Placebo-Controlled, Pharmacokinetic and Pharmacodynamic Study Followed by an Open-Label Arm to Evaluate Efgartigimod IV in Pediatric Participants From 12 Years to Less Than 18 Years of Age With Chronic ITP",
"has_exemption": false,
"start_date": "2025-10-20",
"completion_date": "2028-10-31",
"has_results": false,
"results_due": false,
"sponsor_name": "argenx",
"sponsor_slug": "argenx",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07223021",
"publication_url": "https://clinicaltrials.gov/study/NCT07223021",
"title": "Improving EveNt Free Survival by Optimizing FLUdarabine Exposure During LymphodepletioN for CAR T CEll Therapy: a Randomized, Multi-center Study of Children and Young Adults With B-cell Acute Lymphoblastic Leukemia (INFLUENCE)",
"has_exemption": false,
"start_date": "2025-10-20",
"completion_date": "2028-10-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Memorial Sloan Kettering Cancer Center",
"sponsor_slug": "memorial-sloan-kettering-cancer-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06891885",
"publication_url": "https://clinicaltrials.gov/study/NCT06891885",
"title": "A Prospective, Open-label, Single-arm, Dose-escalation Study of the Safety and Tolerability of a Single Subretinal Uniocular Injection of Allogeneic Induced Pluripotent Stem Cell (iPSC)-Derived Retinal Sheets (DSP-3077) in Adults With Retinitis Pigmentosa (RP)",
"has_exemption": false,
"start_date": "2025-10-23",
"completion_date": "2028-10-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Sumitomo Pharma America, Inc.",
"sponsor_slug": "sumitomo-pharma-america-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06878560",
"publication_url": "https://clinicaltrials.gov/study/NCT06878560",
"title": "EXPAND: A Prospective Study to Evaluate the Safety and Efficacy of the 10 GE Xenokidney in Patients With End-stage Renal Disease (ESRD)",
"has_exemption": false,
"start_date": "2025-10-29",
"completion_date": "2028-10-31",
"has_results": false,
"results_due": false,
"sponsor_name": "United Therapeutics",
"sponsor_slug": "united-therapeutics",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07021989",
"publication_url": "https://clinicaltrials.gov/study/NCT07021989",
"title": "Pembrolizumab and GVD With ctDNA-guided Consolidation in Patients With Relapsed or Refractory Classic Hodgkin Lymphoma: A Multicenter Phase 2 Study of the University of California Hematologic Malignancies Consortium",
"has_exemption": false,
"start_date": "2025-10-31",
"completion_date": "2028-10-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Michael Spinner, MD",
"sponsor_slug": "michael-spinner-md",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07191912",
"publication_url": "https://clinicaltrials.gov/study/NCT07191912",
"title": "A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Long-Term Clinical Benefit of Govorestat in Patients With Charcot-Marie-Tooth-Sorbitol Dehydrogenase Deficiency (CMT-SORD)",
"has_exemption": false,
"start_date": "2025-10-31",
"completion_date": "2028-10-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Applied Therapeutics, Inc.",
"sponsor_slug": "applied-therapeutics-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07225751",
"publication_url": "https://clinicaltrials.gov/study/NCT07225751",
"title": "A Prospective, Randomized, Single-blind, Controlled, Multi-center Study to Assess the Safety and Performance of MagnetOsTM Compared to Autogenous Bone Graft in Patients Undergoing Hindfoot or Ankle Fusions",
"has_exemption": false,
"start_date": "2025-11-25",
"completion_date": "2028-10-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Kuros Biosurgery AG",
"sponsor_slug": "kuros-biosurgery-ag",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05882344",
"publication_url": "https://clinicaltrials.gov/study/NCT05882344",
"title": "Cholinergic Deep Brain Stimulation for Alzheimer's Disease",
"has_exemption": false,
"start_date": "2025-12-01",
"completion_date": "2028-10-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Vanderbilt University Medical Center",
"sponsor_slug": "vanderbilt-university-medical-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07062354",
"publication_url": "https://clinicaltrials.gov/study/NCT07062354",
"title": "A Phase II Study of Combined Amivantamab, Carboplatin and Paclitaxel in Unresectable Locally Recurrent or Metastatic Head and Neck Cancer",
"has_exemption": false,
"start_date": "2025-12-31",
"completion_date": "2028-10-31",
"has_results": false,
"results_due": false,
"sponsor_name": "SWOG Cancer Research Network",
"sponsor_slug": "swog-cancer-research-network",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07225270",
"publication_url": "https://clinicaltrials.gov/study/NCT07225270",
"title": "A Randomized, Open-Label, Phase 3 Study of Rinatabart Sesutecan (Rina-S) Plus Standard of Care Versus Standard of Care as Maintenance Treatment After 2L Platinum-Based Doublet Chemotherapy in Participants With Recurrent Platinum-Sensitive Ovarian Cancer (PSOC)",
"has_exemption": false,
"start_date": "2026-01-15",
"completion_date": "2028-10-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Genmab",
"sponsor_slug": "genmab",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06205589",
"publication_url": "https://clinicaltrials.gov/study/NCT06205589",
"title": "A Phase 2a/2b Study Evaluating Safety, Immunogenicity, and Therapeutic Efficacy of ID93 + GLA-SE Vaccination in Participants With Rifampicin-Susceptible Pulmonary TB",
"has_exemption": false,
"start_date": "2026-02-15",
"completion_date": "2028-10-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections",
"sponsor_slug": "advancing-clinical-therapeutics-globally-for-hivaids-and-other-infections",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04760860",
"publication_url": "https://clinicaltrials.gov/study/NCT04760860",
"title": "a Randomized, Double Blind, Placebo Controlled Clinical Trial Exploring the Target Engagement and Tolerability of Terazosin Hydrochloride in Patients With Dementia With Lewy Bodies",
"has_exemption": false,
"start_date": "2026-10-31",
"completion_date": "2028-10-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Qiang Zhang",
"sponsor_slug": "qiang-zhang",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05517655",
"publication_url": "https://clinicaltrials.gov/study/NCT05517655",
"title": "BEGIN Novel ImagiNG Biomarkers",
"has_exemption": false,
"start_date": "2022-05-01",
"completion_date": "2028-11-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Children's Hospital Medical Center, Cincinnati",
"sponsor_slug": "childrens-hospital-medical-center-cincinnati",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06080503",
"publication_url": "https://clinicaltrials.gov/study/NCT06080503",
"title": "G-FORCE: Phase II Randomized Study of Glottic Larynx Hypofractionated Radiotherapy Versus ConvEntional Radiotherapy",
"has_exemption": false,
"start_date": "2024-03-14",
"completion_date": "2028-11-01",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Texas Southwestern Medical Center",
"sponsor_slug": "university-of-texas-southwestern-medical-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06709495",
"publication_url": "https://clinicaltrials.gov/study/NCT06709495",
"title": "Phase 1/2 Trial to Evaluate the Safety and Efficacy of PEEL-224 in Combination With Vincristine and Temozolomide in Adolescents and Young Adults With Relapsed or Refractory Sarcomas",
"has_exemption": false,
"start_date": "2025-01-27",
"completion_date": "2028-11-01",
"has_results": false,
"results_due": false,
"sponsor_name": "David S Shulman, MD",
"sponsor_slug": "david-s-shulman-md",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06819007",
"publication_url": "https://clinicaltrials.gov/study/NCT06819007",
"title": "A Phase 3, Open-label, Multicenter, Randomized Trial of Trastuzumab Deruxtecan With Bevacizumab Versus Bevacizumab Monotherapy as First-line Maintenance Therapy in HER2-Expressing Ovarian Cancer (DESTINY-Ovarian01/ENGOT-ov89/GEICO144- O/GOG-3112)",
"has_exemption": false,
"start_date": "2025-03-19",
"completion_date": "2028-11-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Daiichi Sankyo",
"sponsor_slug": "daiichi-sankyo",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06973629",
"publication_url": "https://clinicaltrials.gov/study/NCT06973629",
"title": "A Two-Part Phase 3b Randomized, Double-Blind, Placebo-Controlled, Followed by Open-Label Extension, Multicenter Study of the Efficacy and Safety of MSC-NTF (NurOwn) in Participants With With Early Symptomatic and Moderate Disease Presentation in Amyotrophic Lateral Sclerosis (ALS)",
"has_exemption": false,
"start_date": "2025-06-30",
"completion_date": "2028-11-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Brainstorm-Cell Therapeutics",
"sponsor_slug": "brainstorm-cell-therapeutics",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07217301",
"publication_url": "https://clinicaltrials.gov/study/NCT07217301",
"title": "A Randomized, Open-Label, Multicenter, Phase 3 Study Evaluating the Efficacy and Safety of IBI363 Versus Docetaxel in Participants With Unresectable Locally Advanced or Metastatic Squamous Non-Small Cell Lung Cancer With Disease Progression on or After Platinum-Based Chemotherapy and Anti-PD-1/PD-L1 Immunotherapy",
"has_exemption": false,
"start_date": "2025-10-30",
"completion_date": "2028-11-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Fortvita Biologics (USA)Inc.",
"sponsor_slug": "fortvita-biologics-usainc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06782542",
"publication_url": "https://clinicaltrials.gov/study/NCT06782542",
"title": "Single-Arm Phase 2 Study of Olutasidenib, Venetoclax, and Azacitidine in IDH1 Mutated Newly Diagnosed Acute Myeloid Leukemia Patients Who Are Eligible for Intensive Induction Chemotherapy",
"has_exemption": false,
"start_date": "2025-11-01",
"completion_date": "2028-11-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Justin Watts, MD",
"sponsor_slug": "justin-watts-md",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07126561",
"publication_url": "https://clinicaltrials.gov/study/NCT07126561",
"title": "Phase II Open Label Trial of Trastuzumab Deruxtecan (Enhertu, DS-8210) in HER2 Positive Newly Diagnosed Metastatic Esophageal, Gastric, GEJ Cancer Patients With an ECOG Performance Status of 2",
"has_exemption": false,
"start_date": "2025-11-01",
"completion_date": "2028-11-01",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Chicago",
"sponsor_slug": "university-of-chicago",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05931484",
"publication_url": "https://clinicaltrials.gov/study/NCT05931484",
"title": "A Phase 2, Double-Blind, Multi-Center, Placebo-Controlled Clinical Study to Evaluate the Safety, Tolerability, Efficacy, and Pharmacokinetics of FHL-301 in Adult Patients With Parkinson's Disease",
"has_exemption": false,
"start_date": "2027-11-01",
"completion_date": "2028-11-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Forest Hills Lab",
"sponsor_slug": "forest-hills-lab",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06152237",
"publication_url": "https://clinicaltrials.gov/study/NCT06152237",
"title": "A Multicenter, Open Label, Randomized, Dose-Escalation and Dose-Expansion Study of the Safety, Tolerability, and Efficacy of a Single Intrathecal Administration of TSHA-102, an AAV9-Delivered Gene Therapy, for the Treatment of Pediatric Females With Rett Syndrome",
"has_exemption": false,
"start_date": "2023-12-12",
"completion_date": "2028-11-02",
"has_results": false,
"results_due": false,
"sponsor_name": "Taysha Gene Therapies, Inc.",
"sponsor_slug": "taysha-gene-therapies-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07011745",
"publication_url": "https://clinicaltrials.gov/study/NCT07011745",
"title": "A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Parallel Group Study to Evaluate the Safety and Efficacy of KarXT + KarX-EC for the Treatment of Agitation Associated With Alzheimer's Disease",
"has_exemption": false,
"start_date": "2025-07-16",
"completion_date": "2028-11-03",
"has_results": false,
"results_due": false,
"sponsor_name": "Bristol-Myers Squibb",
"sponsor_slug": "bristol-myers-squibb",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05348915",
"publication_url": "https://clinicaltrials.gov/study/NCT05348915",
"title": "An Open-label Extension Study to Evaluate the Long-term Safety of Inclacumab Administered to Participants With Sickle Cell Disease Who Have Participated in an Inclacumab Clinical Trial",
"has_exemption": false,
"start_date": "2022-03-29",
"completion_date": "2028-11-04",
"has_results": false,
"results_due": false,
"sponsor_name": "Pfizer",
"sponsor_slug": "pfizer",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06534983",
"publication_url": "https://clinicaltrials.gov/study/NCT06534983",
"title": "A Randomized Phase II, Double-Blind, Multicenter Study Evaluating the Efficacy and Safety of Autogene Cevumeran Plus Nivolumab Versus Nivolumab as Adjuvant Therapy in Patients With High-Risk Muscle-Invasive Urothelial Carcinoma",
"has_exemption": false,
"start_date": "2024-12-09",
"completion_date": "2028-11-06",
"has_results": false,
"results_due": false,
"sponsor_name": "Hoffmann-La Roche",
"sponsor_slug": "hoffmann-la-roche",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07160244",
"publication_url": "https://clinicaltrials.gov/study/NCT07160244",
"title": "A Phase 3, Randomized, Placebo-Controlled, Double-Blinded Trial to Evaluate the Safety, Tolerability, and Immunogenicity of a Multivalent Group B Streptococcus Vaccine in Healthy Pregnant Women and Their Infants",
"has_exemption": false,
"start_date": "2025-08-25",
"completion_date": "2028-11-06",
"has_results": false,
"results_due": false,
"sponsor_name": "Pfizer",
"sponsor_slug": "pfizer",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06504394",
"publication_url": "https://clinicaltrials.gov/study/NCT06504394",
"title": "A Phase 2 Study to Evaluate the Pharmacokinetics, Efficacy, and Safety of Subcutaneous Pembrolizumab Coformulated With Hyaluronidase (MK-3475A) in Participants With Relapsed or Refractory Classical Hodgkin Lymphoma (rrcHL) or Relapsed or Refractory Primary Mediastinal Large B-cell Lymphoma (rrPMBCL)",
"has_exemption": false,
"start_date": "2024-10-14",
"completion_date": "2028-11-08",
"has_results": false,
"results_due": false,
"sponsor_name": "Merck Sharp & Dohme LLC",
"sponsor_slug": "merck-sharp-dohme-llc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06161519",
"publication_url": "https://clinicaltrials.gov/study/NCT06161519",
"title": "Phase I/II Trial of PLX038 in Primary Central Nervous System Tumors Containing MYC or MYCN Amplifications",
"has_exemption": false,
"start_date": "2024-01-31",
"completion_date": "2028-11-14",
"has_results": false,
"results_due": false,
"sponsor_name": "National Cancer Institute (NCI)",
"sponsor_slug": "national-cancer-institute-nci",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05051033",
"publication_url": "https://clinicaltrials.gov/study/NCT05051033",
"title": "Percutaneous or Surgical Repair In Mitral Prolapse And Regurgitation for ≥60 Year-olds (PRIMARY)",
"has_exemption": false,
"start_date": "2022-02-21",
"completion_date": "2028-11-15",
"has_results": false,
"results_due": false,
"sponsor_name": "Annetine Gelijns",
"sponsor_slug": "annetine-gelijns",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06144606",
"publication_url": "https://clinicaltrials.gov/study/NCT06144606",
"title": "Phase 2 Study of KTE-X19 in Minimal Residual Disease (MRD) Positive B-Cell Acute Lymphoblastic Leukemia (B-ALL)",
"has_exemption": false,
"start_date": "2023-12-26",
"completion_date": "2028-11-15",
"has_results": false,
"results_due": false,
"sponsor_name": "H. Lee Moffitt Cancer Center and Research Institute",
"sponsor_slug": "h-lee-moffitt-cancer-center-and-research-institute",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06571383",
"publication_url": "https://clinicaltrials.gov/study/NCT06571383",
"title": "Weight Maintenance in Adolescents With Obesity; Long-Term Treatment With Semaglutide s.c.2.4 mg Once-weekly",
"has_exemption": false,
"start_date": "2024-09-17",
"completion_date": "2028-11-15",
"has_results": false,
"results_due": false,
"sponsor_name": "Novo Nordisk A/S",
"sponsor_slug": "novo-nordisk-as",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07092527",
"publication_url": "https://clinicaltrials.gov/study/NCT07092527",
"title": "Androgen Effects on the Reproductive Neuroendocrine Axis, 2025 Version",
"has_exemption": false,
"start_date": "2025-12-01",
"completion_date": "2028-11-15",
"has_results": false,
"results_due": false,
"sponsor_name": "University of California, San Diego",
"sponsor_slug": "university-of-california-san-diego",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07214779",
"publication_url": "https://clinicaltrials.gov/study/NCT07214779",
"title": "A Phase 3, Randomized, Open-Label Study of INCB123667 Versus Investigator's Choice of Chemotherapy in Participants With Platinum-Resistant Ovarian Cancer With Cyclin E1 Overexpression",
"has_exemption": false,
"start_date": "2025-12-01",
"completion_date": "2028-11-15",
"has_results": false,
"results_due": false,
"sponsor_name": "Incyte Corporation",
"sponsor_slug": "incyte-corporation",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05490277",
"publication_url": "https://clinicaltrials.gov/study/NCT05490277",
"title": "Vibrotactile Coordinated Reset for the Treatment of Chronic Stroke",
"has_exemption": false,
"start_date": "2026-01-15",
"completion_date": "2028-11-15",
"has_results": false,
"results_due": false,
"sponsor_name": "Stanford University",
"sponsor_slug": "stanford-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07218809",
"publication_url": "https://clinicaltrials.gov/study/NCT07218809",
"title": "A Randomised, Open-label, Phase III Study of AZD5335 Versus Mirvetuximab Soravtansine in FRα-high and AZD5335 Versus Investigator's Choice Chemotherapy in FRα-low Expressing High-grade Platinum-resistant Epithelial Ovarian Cancer Patients (TREVI-OC-01)",
"has_exemption": false,
"start_date": "2025-11-28",
"completion_date": "2028-11-17",
"has_results": false,
"results_due": false,
"sponsor_name": "AstraZeneca",
"sponsor_slug": "astrazeneca",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06499870",
"publication_url": "https://clinicaltrials.gov/study/NCT06499870",
"title": "Optimizing Treatment and Advanced Multi-Imaging Response Evaluation for Very-High-Risk Prostate Cancer (OPTIMAL) - a Phase II Single Arm Study",
"has_exemption": false,
"start_date": "2024-09-06",
"completion_date": "2028-11-19",
"has_results": false,
"results_due": false,
"sponsor_name": "Northwestern University",
"sponsor_slug": "northwestern-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06858735",
"publication_url": "https://clinicaltrials.gov/study/NCT06858735",
"title": "HYPERION CCA: a Phase 2 Trial of Systemic Therapy With or Without Liver-directed Radiation Therapy for Patients With Advanced Intrahepatic Cholangiocarcinoma",
"has_exemption": false,
"start_date": "2025-06-10",
"completion_date": "2028-11-19",
"has_results": false,
"results_due": false,
"sponsor_name": "M.D. Anderson Cancer Center",
"sponsor_slug": "md-anderson-cancer-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07252050",
"publication_url": "https://clinicaltrials.gov/study/NCT07252050",
"title": "Ruxolitinib-Enhanced Conditioning for Pediatric and Young Adult Patients With Symptomatic Sickle Cell Disease Undergoing Haploidentical Hematopoietic Cell Transplantation",
"has_exemption": false,
"start_date": "2026-01-01",
"completion_date": "2028-11-19",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Colorado, Denver",
"sponsor_slug": "university-of-colorado-denver",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06112379",
"publication_url": "https://clinicaltrials.gov/study/NCT06112379",
"title": "A Phase III, Open-label, Randomised Study of Neoadjuvant Datopotamab Deruxtecan (Dato-DXd) Plus Durvalumab Followed by Adjuvant Durvalumab With or Without Chemotherapy Versus Neoadjuvant Pembrolizumab Plus Chemotherapy Followed by Adjuvant Pembrolizumab With or Without Chemotherapy for the Treatment of Adult Patients With Previously Untreated Triple-Negative or Hormone Receptor-low/HER2-negative Breast Cancer (D926QC00001; TROPION-Breast04)",
"has_exemption": false,
"start_date": "2023-11-14",
"completion_date": "2028-11-20",
"has_results": false,
"results_due": false,
"sponsor_name": "AstraZeneca",
"sponsor_slug": "astrazeneca",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07011732",
"publication_url": "https://clinicaltrials.gov/study/NCT07011732",
"title": "A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Parallel Group Study to Evaluate the Safety and Efficacy of KarXT + KarX-EC for the Treatment of Agitation Associated With Alzheimer's Disease",
"has_exemption": false,
"start_date": "2025-07-10",
"completion_date": "2028-11-24",
"has_results": false,
"results_due": false,
"sponsor_name": "Bristol-Myers Squibb",
"sponsor_slug": "bristol-myers-squibb",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07257055",
"publication_url": "https://clinicaltrials.gov/study/NCT07257055",
"title": "Phase 2 Study of BTKi-Rituximab Induction Followed by Glofitamab Consolidation in High Risk Untreated MCL Patients - WINDOW-4 Study",
"has_exemption": false,
"start_date": "2026-05-12",
"completion_date": "2028-11-24",
"has_results": false,
"results_due": false,
"sponsor_name": "M.D. Anderson Cancer Center",
"sponsor_slug": "md-anderson-cancer-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT03686657",
"publication_url": "https://clinicaltrials.gov/study/NCT03686657",
"title": "A 26-week Single Site, Randomized, Double-blind, Active-controlled, Parallel Group, Human PoC Study to Evaluate Superiority of RK-01, Valsartan Plus Celecoxib Addon to Metformin Versus Metformin Alone in Type 2 Diabetes Patients",
"has_exemption": false,
"start_date": "2025-10-10",
"completion_date": "2028-11-26",
"has_results": false,
"results_due": false,
"sponsor_name": "ARKAY Therapeutics",
"sponsor_slug": "arkay-therapeutics",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06947993",
"publication_url": "https://clinicaltrials.gov/study/NCT06947993",
"title": "A Multicenter, Randomized, Double-blind, Placebo-controlled, Phase II Platform Study to Assess the Efficacy and Safety of Investigational Compound(s) in Patients With Moderate to Severe Atopic Dermatitis",
"has_exemption": false,
"start_date": "2025-05-16",
"completion_date": "2028-11-27",
"has_results": false,
"results_due": false,
"sponsor_name": "Novartis Pharmaceuticals",
"sponsor_slug": "novartis-pharmaceuticals",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06184152",
"publication_url": "https://clinicaltrials.gov/study/NCT06184152",
"title": "Contrast Ultrasound vs. Abbreviated MRI for Detection of HCC in Patients With Indeterminate Liver Nodules",
"has_exemption": false,
"start_date": "2023-11-28",
"completion_date": "2028-11-28",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Texas Southwestern Medical Center",
"sponsor_slug": "university-of-texas-southwestern-medical-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07221669",
"publication_url": "https://clinicaltrials.gov/study/NCT07221669",
"title": "An Open-Label Study to Assess the Efficacy and Safety of Multiple Doses of Salanersen (BIIB115) Delivered Intrathecally to Treatment-Naïve, Presymptomatic Infants With Genetically Diagnosed Spinal Muscular Atrophy",
"has_exemption": false,
"start_date": "2026-01-30",
"completion_date": "2028-11-28",
"has_results": false,
"results_due": false,
"sponsor_name": "Biogen",
"sponsor_slug": "biogen",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06649110",
"publication_url": "https://clinicaltrials.gov/study/NCT06649110",
"title": "A Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety, Tolerability and Pharmacokinetics of Single and Multiple Ascending Doses of LTP001 in Healthy Adult Participants (Part A) and to Evaluate the Efficacy and Safety of LTP001 for the Treatment of Participants With Pulmonary Arterial Hypertension (Part B)",
"has_exemption": false,
"start_date": "2024-10-24",
"completion_date": "2028-11-29",
"has_results": false,
"results_due": false,
"sponsor_name": "Novartis Pharmaceuticals",
"sponsor_slug": "novartis-pharmaceuticals",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06593522",
"publication_url": "https://clinicaltrials.gov/study/NCT06593522",
"title": "A Phase 2 Study Evaluating the Efficacy, Safety, Tolerability, and Pharmacokinetics of AMG 193 in Subjects With Methylthioadenosine Phosphorylase (MTAP)-Deleted Previously Treated Advanced Non-Small Cell Lung Cancer (NSCLC)",
"has_exemption": false,
"start_date": "2024-12-26",
"completion_date": "2028-11-29",
"has_results": false,
"results_due": false,
"sponsor_name": "Amgen",
"sponsor_slug": "amgen",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT03301506",
"publication_url": "https://clinicaltrials.gov/study/NCT03301506",
"title": "ASSURE: An Open Label Long-Term Study to Evaluate the Safety and Tolerability of Seladelpar in Subjects With Primary Biliary Cholangitis (PBC)",
"has_exemption": false,
"start_date": "2017-12-12",
"completion_date": "2028-11-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Gilead Sciences",
"sponsor_slug": "gilead-sciences",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04781972",
"publication_url": "https://clinicaltrials.gov/study/NCT04781972",
"title": "Multimodal Brain Imaging of the Neural Effects of Methylphenidate in Patients With ADHD",
"has_exemption": false,
"start_date": "2021-07-27",
"completion_date": "2028-11-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Johns Hopkins University",
"sponsor_slug": "johns-hopkins-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05079841",
"publication_url": "https://clinicaltrials.gov/study/NCT05079841",
"title": "The Stimulation To Induce Mothers (STIM) Study: A Parallel Group Randomized Controlled Trial",
"has_exemption": false,
"start_date": "2021-11-15",
"completion_date": "2028-11-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Yale University",
"sponsor_slug": "yale-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05228145",
"publication_url": "https://clinicaltrials.gov/study/NCT05228145",
"title": "A Phase 1/2 Intracerebroventricular and Intravitreal Administration of NGN-101 for Treatment of Neuronal Ceroid Lipofuscinosis (NCL) Subtype 5 (CLN5) Disease",
"has_exemption": false,
"start_date": "2022-01-31",
"completion_date": "2028-11-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Neurogene Inc.",
"sponsor_slug": "neurogene-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05076617",
"publication_url": "https://clinicaltrials.gov/study/NCT05076617",
"title": "An Open-Label, Multicenter, Outpatient Extension Study to Evaluate the Safety and Tolerability of Staccato Alprazolam in Study Participants 12 Years of Age and Older With Stereotypical Prolonged Seizures",
"has_exemption": false,
"start_date": "2022-02-03",
"completion_date": "2028-11-30",
"has_results": false,
"results_due": false,
"sponsor_name": "UCB Biopharma SRL",
"sponsor_slug": "ucb-biopharma-srl",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05121376",
"publication_url": "https://clinicaltrials.gov/study/NCT05121376",
"title": "A Phase 1/2 Open-Label, Dose-Escalation Study to Determine the Safety Tolerability & Efficacy of BMN 331 an AAV Vector-Mediated Gene Transfer of Human SERPING1 Gene in Subjects With HAE Due to Human C1-INH Deficiency",
"has_exemption": false,
"start_date": "2022-02-15",
"completion_date": "2028-11-30",
"has_results": false,
"results_due": false,
"sponsor_name": "BioMarin Pharmaceutical",
"sponsor_slug": "biomarin-pharmaceutical",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05281731",
"publication_url": "https://clinicaltrials.gov/study/NCT05281731",
"title": "Sonobiopsy for Noninvasive and Sensitive Detection of Glioblastoma",
"has_exemption": false,
"start_date": "2022-04-18",
"completion_date": "2028-11-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Washington University School of Medicine",
"sponsor_slug": "washington-university-school-of-medicine",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05832229",
"publication_url": "https://clinicaltrials.gov/study/NCT05832229",
"title": "Liver Cirrhosis Network (LCN) Rosuvastatin Efficacy and Safety for Cirrhosis in the United States (RESCU): A Double-Blind Randomized, Placebo-Controlled Phase 2 Study",
"has_exemption": false,
"start_date": "2023-10-11",
"completion_date": "2028-11-30",
"has_results": false,
"results_due": false,
"sponsor_name": "National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)",
"sponsor_slug": "national-institute-of-diabetes-and-digestive-and-kidney-diseases-niddk",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05796375",
"publication_url": "https://clinicaltrials.gov/study/NCT05796375",
"title": "Replacing Invasive Cystoscopy With Urine Testing for Non-muscle Invasive Bladder Cancer Surveillance",
"has_exemption": false,
"start_date": "2023-11-17",
"completion_date": "2028-11-30",
"has_results": false,
"results_due": false,
"sponsor_name": "White River Junction Veterans Affairs Medical Center",
"sponsor_slug": "white-river-junction-veterans-affairs-medical-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06157528",
"publication_url": "https://clinicaltrials.gov/study/NCT06157528",
"title": "Diagnosis of Pelvic Endometriosis: a Preliminary Study on the Added Value of R2*MFGRE Sequence in MRI",
"has_exemption": false,
"start_date": "2023-12-20",
"completion_date": "2028-11-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Zhenshen Ma",
"sponsor_slug": "zhenshen-ma",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06169852",
"publication_url": "https://clinicaltrials.gov/study/NCT06169852",
"title": "Stimulus-Evoked Directional Field Potentials to Guide Subthalamic and Pallidal DBS for PD",
"has_exemption": false,
"start_date": "2024-01-12",
"completion_date": "2028-11-30",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Alabama at Birmingham",
"sponsor_slug": "university-of-alabama-at-birmingham",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06075953",
"publication_url": "https://clinicaltrials.gov/study/NCT06075953",
"title": "DCIS: RECAST Trial -Ductal Carcinoma In Situ: Re-Evaluating Conditions for Active Surveillance Suitability as Treatment: a Breast Cancer Prevention Pilot Study",
"has_exemption": false,
"start_date": "2024-02-17",
"completion_date": "2028-11-30",
"has_results": false,
"results_due": false,
"sponsor_name": "QuantumLeap Healthcare Collaborative",
"sponsor_slug": "quantumleap-healthcare-collaborative",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05940324",
"publication_url": "https://clinicaltrials.gov/study/NCT05940324",
"title": "Examining Mu Opioid Mechanisms of Ketamine's Rapid Effects in OCD (MKET2)",
"has_exemption": false,
"start_date": "2024-02-24",
"completion_date": "2028-11-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Stanford University",
"sponsor_slug": "stanford-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
}
]
}